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Abstract 
 
Cyclic di-guanosine-monophosphate (c-di-GMP) has been recognized as a 
second messenger in bacteria controlling multiple cellular processes such as biofilm 
formation, motility, and virulence.  Proteins containing GGDEF and EAL domains 
are engaged in the synthesis and degradation, respectively, of cyclic di-GMP.  Some 
bacteria contain multiple proteins with GGDEF and EAL domains. The genome of 
Mycobacterium tuberculosis encodes only one protein (Rv1354c) which contains a 
GGDEF domain.  This protein also contains a tandem EAL.  The function of this 
protein in mycobacteria has not yet been determined. 
In this study, the orthologue of Rv1354c was investigated in Mycobacterium 
smegmatis (MSMEG_2196).  The expression of MSMEG_2196 in M. smegmatis was 
altered by constructing sense and antisense expressing strains.  The effect of the 
altered expression of MSMEG_2196 on M. smegmatis was tested under carbon, 
oxygen, phosphorous, and nitrogen limited growth conditions.  There was no 
significant effect on growth in either the antisense or sense expressing strains grown 
under nutrient-rich, or carbon-, or oxygen-, or phosphorous limitation conditions.  
However, a growth effect was observed in the antisense expressing strain when 
grown under nitrogen-limited conditions.  In particular, at mid stationary-phase 
(1,800 min) the MSMEG_2196 antisense strain had an OD600 value of 0.60, 
compared to that of the control M. smegmatis/pMind strain (OD600 value of 1.09).  
These results were further confirmed by the low colony forming units measures 
observed in MSMEG_2196 antisense strain.  Proteomic analysis was carried out on 
the MSMEG_2196 antisesne expressing strain grown in the nitrogen-limited 
condition.  Proteins that were differentially expressed were identified by mass 
spectrometry.  A number of the proteins that were down-regulated in the antisense 
expressing strain are important in the survival of the bacteria under nitrogen-limited 
conditions.   
This study indicates a role for MSMEG_2196 in growth or survival of 
mycobacteria under nitrogen-limitations. 
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1  Introduction 
 
 1.1   Tuberculosis 
Tuberculosis (TB), is caused by Mycobacterium tuberculosis, a slow growing 
(doubling time of 15-20 hrs), acid fast, rod shaped bacilli, 0.2-0.5 µm in size. TB is 
an airborne communicable disease, transmitted from person to person via the 
respiratory system and can spread from the lungs to become a systemic infection if 
left untreated [147].  TB is still considered a “global epidemic infectious disease” and 
a major cause of death worldwide.  In 2006, the World Health Organization (WHO) 
reported 9.2 million new cases worldwide and 1.7 million deaths caused by TB [147].   
M. tuberculosis is a successful pathogen that evades the immune system of the host, 
establishing a chronic latent infection where it may silently persist inside a hostile 
environment such as the granuloma in the lung, specifically in pulmonary alveoli 
[141] (Reviewed in [140]).  The granuloma is a nodule consisting of epithelioid 
macrophages, T and B lymphocytes, plasma cells, and fibroblasts [141] (Reviewed in 
[140]).  Inside the granuloma, M. tuberculosis can escape chemotherapy and remain 
in the latent stage for many years [141 and 148] (Reviewed in [140] and [142]). This 
acts as a reservoir from which patients can develop active disease, especially patients 
who are immuno-compromised such as those with HIV or the elderly [141] 
(Reviewed in [140] and [142]).  In addition, none of the conventional anti-
tuberculosis drugs are very effective against the “dormant bacilli”.    
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Some of the studies carried out on M. tuberculosis have focused on the 
environmental conditions of the granuloma, which have been proposed to be anoxic, 
and nutritionally starved (Reviewed in [47]). The granulomatous lesion; an in vivo 
environment encountered by the dormant bacilli, presents a nutritionally deprived and 
an anoxic environment [125] (Reviewed in [47]).  It has been shown that adaptation 
of M. tuberculosis to the in vivo environment involves differential expression of 
genes that respond to iron limitation, alternative carbon metabolism, and cellular 
hypoxia [134].  Based on these observations, anaerobic and starved cultures are used 
as models to study the molecular basis of dormancy.  Another study has shown that 
upon starvation, mycobacterial species such as M. tuberculosis, M. kansasii and M. 
pheli, become “chromophobic”, whereby they become resistant to staining and can 
survive for at least two years under starvation [94].  These starved mycobacterial 
cultures can regain their acid-fast bacilli stain morphology once they are transformed 
into nutrient rich media [94]. These observations suggest physiological similarities 
between the M. tuberculosis in TB and the studied mycobacterial species in 
nutritionally starved cultures [94].   
An increasing problem in TB treatment is the emergence of multi-drug resistant 
TB (MDR-TB), and extensively-drug resistant TB (XDR-TB).  MDR-TB is resistant 
to the first line of anti-TB drugs, isoniazid and rifampicin [147].  XDR-TB is resistant 
to MDR-TB drugs (isoniazid and rifampicin), one of the injectable aminoglycosides 
i.e. amikacin, kanamycin, or capreomycin, and one of the fluoroquinolones [147].  
The WHO has estimated that there are 490,000 new cases of MDR-TB and 40,000 
new cases of XDR-TB each year [147].  There is an urgent need to discover new 
more effective anti-TB drugs to reduce the treatment time, treat cases of MDR-TB 
and XDR-TB, and to treat latent TB infections. 
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1.2   Finding new drug targets to treat TB 
To develop new drugs for the treatment of TB, new targets are required.  The 
bacterial signal transduction system is a possible target against which new drugs can 
be developed for the treatment of TB.  The signal transduction system senses changes 
in the bacterium’s external environment and regulates a range of important processes 
including nutrient uptake, environmental stress tolerance, antibiotic resistance, and 
virulence gene expression [9].  The most widely known nucleotides involved in signal 
transduction systems are cyclic nucleotides. 
Cyclic nucleotides are components of a wide variety of different signalling 
pathways [9].  3’, 5’- adenosine cyclic monophosphate (cAMP) and 3’, 5’-guanosine 
cyclic monophosphate (cGMP) were the first cyclic nucleotides discovered, about 50 
years ago (Reviewed in [62]).  Both are known as “key universal second messengers” 
[9], and function in signal transduction pathways controlling many important cellular 
processes such as chemotaxis, differentiation, and proliferation (Reviewed in [62]). In 
some bacterial pathogens, they are also necessary for sensing and responding to the 
host environment [9].  Studies on cAMP expression in mycobacteria grown in the 
presence of glycerol have revealed an intracellular expression level 100-200 fold 
higher than in Escherichia coli [96].  The expression levels of cAMP in M. smegmatis 
are a few hundred-fold higher than in Saccharomyces carlbergensis and 
Chlamydomonas reinhardtii (Reviewed in [89]).  cAMP was also found to be present 
in the growth media of mycobacteria culture, suggesting an ability to secrete cAMP 
(Reviewed in [89]). 
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Studies on M. tuberculosis infected macrophages have shown that cAMP 
levels increase in macrophages upon infection [84].  Other studies have demonstrated 
cAMP to be involved in reducing phagocyte activity in Bordetella pertusis and 
Bacillus anthracis [28, 146].  Similar results have been proposed in studies on cAMP 
in Mycobacterium microti and Mycobacterium bovis BCG [71, 84].  However, there 
is no clear evidence to show that the observed cAMP in infected macrophages is 
mycobacterial in origin and/or is produced by the host. 
Studies based on the role of cyclic nucleotides in bacterial adaptive responses 
to nutritional stress have demonstrated a mechanism called the ‘stringent response’ 
[95].  A feature of the stringent response is the accumulation of the nucleotide 
guanine tetraphosphate, ppGpp.  This nucleotide down regulates the expression of 
RNA stabilizing proteins, ribosomal proteins and lipid biosynthetic enzymes, while it 
activates other proteins, which are involved in stress resistance [95]. An accumulation 
of ppGpp has been shown to occur in M. tuberculosis, M. leprae and M. smegmatis 
[95], suggesting a ppGpp-like nucleotide may act as a key regulator of M. 
tuberculosis survival during the stationary phase [95].   
Even though studies on cyclic nucleotides such as cAMP have been carried out 
in the mycobacterium sp. M. smegmatis, M. tuberculosis, M. phlei, and M. bovis BCG 
[85, 96, and 97], the mechanisms behind cyclic nucleotide signalling in mycobacteria 
are not fully understood.  However, using anti-TB drugs targeting cAMP and/or 
cGMP may not be suitable because of their wide functional importance in host 
eukaryotic cells. 
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  Recently, a new bacterial cyclic nucleotide, cyclic di-guanosine 
monophosphate (c-di-GMP), has been described.  This nucleotide act as a “second 
messenger” during biofilm formation, virulence, motility, and survival signalling 
pathways [15, 24, 25, 26, 36, 37, 42, 44, 49, 55, 57, 72, 74, 75, and 82].  Its presence 
in eukaryote cells has not been recorded to date.  Furthermore, no studies have been 
carried out to address the role of c-di-GMP in M. tuberculosis pathogenesis and 
survivability under environmental stress response.  
Investigating the role of c-di-GMP in M. tuberculosis could provide important 
knowledge of the mycobacterial survival signalling pathways, drug resistance and 
stress response.  It may also offer new hopes for novel drugs targeting TB epidemic 
infection, and lead to the creation of new anti-TB drugs that target mechanisms such 
as the survival-signalling pathways and the stress response.   
 
 
 
1.3   The role of cyclic di-GMP in bacteria 
In the 1980s, a third cytoplasmic cyclic nucleotide, c-di-GMP (Figure 1.3.1), 
was discovered by Moshe Benziman [11] (Reviewed in [111]).  His work was based 
on the process involved in controlling glucose condensation into cellulose polymers 
in Acetobacter xylinum (Reviewed in [111]).  It was demonstrated that c-di-GMP was 
controlled through the opposing activities of the two enzymes di-guanylate cyclase 
(DGC) and phosphodiesterases A (PDEA) [129].   
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New studies on c-di-GMP provide evidence that the novel c-di-GMP is a “common 
ubiquitous signalling system” that is used in many bacteria (Reviewed in [109] and 
[110]). 
 
 
 
Figure 1.3.1 – Structure of c-di-GMP Chemical structure of c-di-GMP second messenger.  Figure was 
reproduced with permission from the author [112]. 
 
 
 
 
All of the studies investigating the function of c-di-GMP in bacteria conclude 
that high cellular levels of c-di-GMP causes attachment, aggregative behaviour, 
biofilm formation, and the production of exopolysaccharide [68 and 130] (Reviewed 
in [62], [109] and [111]).  Decreased cellular levels of c-di-GMP promote motility 
and the production of virulence factors in humans, animals, and plant pathogens [2, 
15, 16, 17, 24, 36, 37, 42, and 44]. 
Biofilm formation in mycobacteria spp. such as M. fortuitum, M. marinum and 
M. smegmatis has been recorded previously [48, 49, and 50] (Reviewed in [100]).  It 
has been proposed that the formation of biofilm in mycobacteria could contribute to 
its immune system resistance, as well as to antibiotic resistance [22 and 117].
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Biofilm formation in other bacteria such as Bordetella pertussis and Vibrio cholerae, 
is believed to cause chronic infection in the host [42 and 48] (Reviewed in [100]).  
Virulence genes encoding c-di-GMP have been discovered in Salmonella 
typhimurium, V. cholerae, B. pertussis and Pseudomonas aeruginosa [5, 55, 76, 77, 
135, and 137].   
It is possible that M. tuberculosis uses c-di-GMP as a signalling molecule to 
sense its surrounding environment, and to escape phagosytosis by aiding in the 
process of blocking the maturation of mycobacterial phagosome into the 
phagolysosome either directly or indirectly.  It is also possible that c-di-GMP is 
involved in the mechanism of the latent state characteristic of M. tuberculosis in that 
once the host becomes immuno-compromised c-di-GMP sends down-stream signals 
to activate many transcriptional pathways that lead to active TB in the host.   These 
possibilities lead to the hypothesis that c-di-GMP acts as a global regulator in 
mycobacteria.   
 
 
 
1.4 The synthesis and degradation of c-di-GMP 
Proteins involved in the synthesis and degradation of c-di-GMP contain 
GGDEF and/or EAL domains.  In some cases, GAF and/or PAS domains are found 
next to GGDEF and/or EAL domains [113] (Reviewed in [109], [110] and [112]).  
The domain names originate from the conserved sequence motifs Gly-Gly-Asp-Glu-
Phe (GGDEF) (Reviewed in [114]), and Glu-Ala-Leu (EAL) [118].   
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The GAF domain name originates from c-GMP-specific and stimulated 
phosphodiesterase/Adenylate cyclase (Anabaena)/ FhlA (E. coli) [116].  PAS and 
GAF domains are structurally similar, but are unrelated in amino acid sequences 
leading to different ligand-binding molecules [116].   
The GGDEF domain was discovered in Caulobacter crescentus [53].  This 
bacteria has a protein named PleD that contains a C-terminal GGDEF domain and 
two N-terminal receiver domains (Reviewed in [62]).  The PleD protein function as a 
response regulator, controlling cell differentiation in the swarmer (flagellated form) to 
stalked (surface attached form) cell transition (Reviewed in [41]).  Biochemical 
examinations conducted on the PleD protein of C. crescentus gave direct biochemical 
evidence that the GGDEF domain possesses DGC activity (the GGDEF domain 
convert two molecule of GTP to c-di-GMP) [101] (Figure 1.3.2).  Other in vitro 
biochemical analyses in bacteria such as S. typhimurium, Pseudomonas fluorescens, 
Yersinia pestis, V. cholerae, and E. coli, strengthened the association of the GGDEF 
domain proteins with DGC activity [68, 72, 75, 82, and 122].  Other studies have 
demonstrated that over-expression of genes encoding GGDEF domain proteins 
increased cellular levels of c-di-GMP [101, 122, and 136].   
The EAL domain was discovered in a protein named BvgR, a repressor of 
virulence gene expression, in B. pertussis [87].  The regulation of virulence factors in 
B. pertussis depends on the bvg locus, which encodes BvgA and BvgS [87].  It has 
been proposed that the BvgS protein response to environmental signals and interacts 
with BvgA (a transcriptional regulator) [87].   
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When genes encoding the “major virulence factors” are activated, virulence-response 
genes are turned off in a BvgR-dependent manner [87].  This observation has 
concluded BvgR to be part of signal transduction system in B. pertussis [87].  Later 
studies of A. xylinum found similar domains to that of BvgR named EAL domains, 
due to their conserved residues.  This EAL domain in A. xylinum was found to be 
located next to a GGDEF domain that regulates cellulose synthesis [136].   
Studies conducted on genes encoding only EAL domains demonstrated a 
decreased level of cellular c-di-GMP; and gave indirect evidence for EAL domain 
proteins as having a PDE-A activity [122, 131, 136, and 137].  Biochemical studies 
based on proteins containing EAL domains gave direct evidence of EAL domains as 
having a PDE-A activity [24, 25, and 118] (Rviewed in [109]).  Therefore proteins 
with GGDEF domains have a DGC activity (synthesises c-di-GMP), and proteins 
with EAL domains have a PDE-A activity (degrades c-di-GMP) (Figure 1.3.2).  
 
 
 
Figure 1.3.2 – Synthesis and degradation of c-di-GMP:  GGDEF domains have DGC activity that 
produces c-di-GMP from 2-GTP.  EAL domains contain PDE-A activity that hydrolyses c-di-GMP to the linear 
form pGpG (2 GMP).   
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The GAF domain was originally described as a “non-catalytic cGMP-binding 
domain” conserved in cyclic nucleotide phosphodiesterases [20].  Later studies 
described it as “cyanobacteria adenylate cyclase” and histidine kinase [6], and it is 
often found linked with GGDEF and/or EAL domains [6].  Proteins with GAF 
domain are shown to have functions in gene regulation [6], light detection and 
signalling in plants and cyanobacterial phytochromes [121] (Reviewed in [89]), 
nitrogen fixation in bacteria [65], feedback control of a cyanobacterial adenylyl 
cyclase by cAMP-binding [69], and the two-component sensor histidine kinase in 
viruses, bacteria, and plants (Reviewed in [41] and [139]).  Therefore most of the 
literature based on c-di-GMP and cell signalling has shown GAF domains to play role 
in signal inputs from the surrounding environments [19, 36, 57, 66, 70, 103, and 145], 
and/or function in adjusting GGDEF-EAL domain activities (Reviewed in [132]).   
No previous studies have been carried out on c-di-GMP and its domains 
(GAF-GGDEF-EAL) in mycobacteria.  c-di-GMP seems to be ubiquitous in the 
kingdom of prokaryotes with some bacteria having multiple copies of GGDEF-EAL 
domains.  For example, P. aeruginosa has 17 GGDEF, 5 EAL and 16 GGDEF-EAL 
domain proteins (Reviewed in [41]), and V. cholerae has 31 GGDEF, 22 EAL, and 10 
GGDEF-EAL domain proteins (Reviewed in [41]).  The M. tuberculosis genome 
contains only one protein with GAF-GGDEF-EAL domains designated as Rv1354c 
[7], and three proteins containing GAF domain i.e. Rv1354c, Rv2027c, and Rv3132c 
[7].  Studies have been conducted on the GAF domain of Rv3132c protein, and it was 
found to be activated through the binding of molecules such as oxygen and nitric 
oxide [116].   
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Since c-di-GMP is involved with proteins containing GGDEF and/or EAL 
domains, Rv1354c was investigated in this study using M. bovis and M. smegmatis as 
the model organism.  Rv1354c was listed as a “conserved hypothetical protein”, it 
consists of 623 amino acids, and its function in mycobacteria is not known.  The 
focus of this study was to investigate possible role of Rv1354c in M. smegmatis 
responses to different environmental stresse conditions. Sense and antisense 
experiments were conducted in M. smegmatis. Using nutrient-rich, or carbon-, 
oxygen-, or phosphorous-limited conditions, the altered expression of Rv1354c, in M. 
smegmatis, was examined in term of cell growth effect. Proteomic analysis was 
carried out to determine possible differential protein expression under limited 
conditions. Mutagenesis experiments, such as overlap PCR were applied to construct 
the knock-out of Rv1354c strain in M. bovis and M. smegmatis.  
Most of the work involved with M. bovis was carried out at the AgResearch 
PC3 laboratory (Wallaceville, New Zealand).  Since M. smegmatis is less virulent all 
of the work was carried out at PC2 Microbiology laboratory (Victoria University of 
Wellington, New Zealand).    
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1.5 Aims 
1.5.1 Determine whether a c-di-GMP enzyme is encoded by M. tuberculosis 
genome 
To find out whether the M. tuberculosis genome encodes c-di-GMP enzyme, 
the M. tuberculosis genome will be searched for GGDEF and or/EAL domains using 
TIGERFAMs database. 
 
 
 
1.5.2 Construction of sense and antisense c-di-GMP strains in M. smegmatis   
To determine the possible role of c-di-GMP in M. smegmatis a sense and an 
antisense strain will be constructed. The construction of c-di-GMP sense and 
antisense strains will be conducted by inserting the c-di-GMP PCR fragment into the 
expression vector pMind.  Tetracycline will be used to conditionally control the 
expression of the sense and antisense fragments in M. smegmatis. 
 
 
 
1.5.3 Investigate the effect of the changed expression of c-di-GMP sense and 
antisense on the physiology of M. smegmatis  
To examine the presence of any growth effect caused by the altered 
expression of c-di-GMP in M. smegmatis, Hartman de Bont (HdeB) oxygen, nitrogen, 
phosphorous, and carbon minimal growth media will be used.   
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1.5.4 Proteomic analysis of MSMEG_2196 in HdeB growth limited media 
To determine possible differential protein expression between the c-di-GMP 
sense and antisense strains under limited growth conditions, proteomic analysis will 
be carried out on any significant growth effect observed in the HdeB limited growth 
assays. 
 
 
 
1.5.5 Mutation of c-di-GMP, in M. bovis and   M. smegmatis, respectively  
To construct a knock-out of c-di-GMP in M. bovis and M. smegmatis, overlap 
PCR extension will be used.  The c-di-GMP deletion fragments will be inserted into 
the suicide pUHA778 plasmid to generate the knockout vector.   
To test c-di-GMP for virulence and pathogencity in M. bovis, mice will be 
used where they will be infected with the M. bovis c-di-GMP mutant. The M. 
smegmatis c-di-GMP mutant will be examined for pathogencity in macrophages, and 
for growth and developmental effects in a series of growth curves under limited 
growth conditions in the log and stationary phase. 
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2.   Materials and Methods 
 
 
 
2.1 Bacterial strains, plasmids and culture conditions  
The bacterial strains used in this study were M. smegmatis mc²155 (Victoria 
University), and M. bovis WAg203, provided by AgResearch (Wallaceville, New 
Zealand).  M. smegmatis mc²155 cultures were grown overnight in Luria-Bertani broth 
[LB] (Invitrogen, Auckland, New Zealand) at 37 ºC (composition (g/L) – 10.0 peptone 
from casein, 5.0 yeast extract, 10.0 NaCl) or on LB agar [LA] (Invitrogen, Auckland, 
New Zealand) (compostion [g/L] – 10.0 peptone from casein, 5.0 yeast extract, 10.0 
NaCl2, 12.0 Agar).  When grown in LB, 0.1% Tween 80 (MERCK, New Zealand) was 
used to avoid clumping of the M. smegmatis cells.   E. coli DH5α cells were used and 
they were grown at 37 ºC in LB and/or LA.   
The Cloning vectors used were pGEM-T Easy (Promega, Auckland, New Zealand) 
and pCR2.1 (Invitrogen, Auckland, New Zealand), following manufacturer’s instructions.  
All work with these vectors was carried out on LA with Ampicillin (Sigma-Aldrich, New 
Zealand) at 200 µg/mL, IPTG (BioLine, Australia) at 100 µg/mL and Xgal (BioLine, 
Australia) at 40 µg/mL.  pMind (Appendix 6.1.2) vector was used to construct the 
antisense and sense strains as described previously [14].  This plasmid was grown using 
LA/LB with Kanamycin (Sigma-Aldrich, New Zealand) at 50 μg/mL and Hygromycin 
(Sigma-Aldrich, New Zealand) at 50 μg/mL, and incubated at 37 ºC.  pUHA778 with Pac 
I site (Appendix 6.1.1) was used as the knock out vector, obtained from AgResearch 
(Wallaceville, New Zealand).  Work on this plasmid was carried out mainly on LA and 
/or on LB with Ampicillin at 100 µg/mL and Hygromycin at 50 µg/mL, grown at 37 ºC.  
Chapter 2:  Materials and Methods 
 15
Hartman-de Bonts (HdeB) minimal media [125] was used to perform growth assays 
under limited conditions.   
 
2.2  Bioinformatics of c-di-GMP in the genome of mycobacteria  
A literature search was carried out to find genes involved with c-di-GMP in bacteria 
such as V. cholerae and A. xylinum.  Most of the proteins involved in the synthesis and 
degradation of c-di-GMP contained GAF, GGDEF, and or EAL domains.   
The M. tuberculosis genome was searched for a GGDEF domain using “The 
Institute for Genomic Research” (TIGR) website [133] with text search.  Rv1354c was 
the only gene in M. tuberculosis genome containing the three domains GAF-GGDEF-
EAL.  To find homologue gene of Rv1354c in M. smegmatis and M. bovis, Rv1354c gene 
sequences were blasted against the M. smegmatis and M. bovis genome, respectively, 
using (www.vge.ac.uk/blast/blast.cgi) database.  The orthologue of Rv1354c in M. bovis 
is Mb1389c, and in M. smegmatis is MSMEG_2196. Rv1354c and Mb1389c are 
annotated as “conserved hypothetical protein” in M. tuberculosis and M. bovis, 
respectively. MSMEG_2196 is annotated as a “sensory box/response regulator” protein.  
Pfam (www.sanger.ac.uk/Software/Pfam/) was also used to run the selected M. bovis and 
M. smegmatis proteins for domain structure view. 
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2.3 Altered expression of MSMEG_2196 in M. smegmatis 
 
2.3.1 Preparation of genomic DNA 
Throughout this study, the cultured cells, either sub-cultured from LB or 
inoculated from LA plates, were grown into 3 mL of LB and incubated at 37 ºC 
overnight.  The cultures were then collected by centrifuging at 7,000 x g for 15 mins, 
and genomic DNA was extracted using the phenol-chloroform protocol as follow:  
cells were resuspended in 400 µL of Tris-EDTA buffer (TE buffer).  The 
resuspension was followed by the addition of lysozyme (Sigma-Aldrich, New 
Zealand) to a final concentration of 2 mg/mL; the cells were then mixed gently and 
incubated at 37 °C in a water bath for 30 mins.  SDS (Invitrogen, New Zealand) was 
added at a final concentration of 1 % followed by the addition of 0.2 mg/mL of 
proteinase K (Sigma-Aldrich, New Zealand).  Then the cell suspension was mixed 
and incubated in a water bath set at 65 °C for 15 mins.  400 µL of Phenol (MERCK, 
Australia) was added to the cell suspension and mixed.  Then the suspension mixture 
was centrifuged at 16,000 x g for 10 mins, after which the upper aqueous layer was 
removed to a fresh microfuge tube leaving behind the white precipitate.  400 µL of 
chloroform (Ajax Finechem Ltd., New Zealand) was added to the aqueous layer and 
mixed, then centrifuged at 16,100 x g for another 10 mins.  The aqueous layer was 
once again removed to a fresh microfuge tube.  99 % cold ethanol (Ajax Finechem 
Ltd., New Zealand) was added at 2.5 volume, and sodium acetate, pH 5.2 (Sigma-
Aldrich, New Zealand) was added at a final concentration of 0.1 M.  The solution was 
then mixed and centrifuged at 16,100 x g for 20 mins.  400 µL of cold 70 % ethanol 
was then added to the supernatant and centrifuged at 16,100 x g for 5 mins.  The 
pellets were then allowed to dry in a heating block set at 37 °C until dry.  200 µL of 
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sterile-distilled water was added and the DNA stored at 4 °C.  This protocol can also 
be found in Sambrook and Russell (Volume 1- 6.4-6.11) [115]. 
 
 
 
2.3.2 Preparation of Mycobacterium smegmatis mc2155 electroporation-
competent cells 
M. smegmatis mc2155 electroporation-competent cells were prepared as 
outlined in Sambrook and Russell (Volume 1, 1.12-1.14) [115].  Briefly, M. 
smegmatis cells were inoculated from LA plates into 10 mL LB (no antibiotics) and 
incubated overnight at 37 ºC.  The next day, 1/5 of the overnight culture were sub-
inoculated into 100 mL LB (no antibiotics) and incubated during the day at 37 ºC, 
cells were harvested when the OD600 absorbance was between 0.5 and 1.0.  Cells 
were divided into two 50 mL Falcon tubes (Labserve, New Zealand), then incubated 
on ice for 20 mins, and then pelleted for 15 mins at 9,000 x g at 4 ºC.  The pellets 
were resuspended in 50 mL of 10 % cold glycerol and pelleted for 15 mins at 9,000 x 
g at 4 ºC, once again, the cells were resuspended in 20 mL of 10 % cold glycerol, and 
cells were pelleted for another 15 mins at 9,000 x g at 4 ºC.  Finally, the pellets were 
resuspended in 2 mL of 10 % glycerol and 100 µL aliquots were dispensed into 
chilled microfuge tubes and stored at -80 ºC or used immediately for electroporation.    
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2.3.3 PCR of MSMEG_2196 
The final concentration of PCR reagents used, to amplify MSMEG_2196 
gene, were 0.16 mM dNTPs, 0.8 µM of each primer (Ms_2196 F1 and Ms_2196 R1), 
2.5 mM MgSO4, 1x PCR reaction buffer, 0.05 U/µL Platinum Taq polymerase. 
DMSO, when used, was added at a concentration of 2.5 %, respectively (all of the 
PCR reagents and primers were purchased from Invitrogen, Auckland, New Zealand).   
3.0 µL of template DNA (0.3 µg) was added to a 25 µL reaction.  The PCR 
conditions are shown in table 2.3.1 and primers in table 2.3.2.   
All of the PCR products were run on 1 % low melting temperature agarose 
gels (Roche Applied Science, Auckland, New Zealand) with ethidium bromide (1 
µg/mL) for DNA detection.  For PCR product purification, the Roche DNA gel 
purification kit (Roche Applied Science, Auckland, New Zealand) was used 
following the manufacturer’s instructions. 
 
 
 
Steps  Temperature 
(°C) 
Time 
(mins) 
1. Denaturation 94 5.0 
2. Annealing 50 1.0 
3. Extension  68 2.0 
4. Steps 1-3 repeat 30 times   
5. Extension  68 10 
 
Table 2.3.1:  PCR conditions used to amplify MSMEG_2196 fragment 
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Primer 
name 
Enzyme 
site 
Sequence 
Ms_2196 F1 Pac I CTAGTTAATTAAGACGTCGTAACAGGGCTGAGC 
Ms_2196 R1 Pac I CTAAGTTAATTAAGGGGCGCCGCACTCACATGCG 
 
Table 2.3.2:  MSMEG_2196 antisense and sense construction primers.  Nucleotides in bold letters 
represent the enzyme site. 
 
 
 
2.3.4   Ligation of MSMEG_2196 into pCR 2.1 cloning vector 
3 µL of the gel purified MSMEG_2196 PCR product was ligated into pCR 2.1 
cloning vector (Invitrogen, Auckland, New Zealand), ligation reactions were 
performed with 0.4 U/µL of T4 DNA ligase (Invitrogen, New Zealand), 1x ligation 
buffer (Invitrogen, Auckland, New Zealand), and 1 ng/µL of pCR2.1 (Invitrogen, 
New Zealand) in a total volume of 10 µL.  The ligation reaction was incubated at 14 
ºC for 4 hrs. 
 
 
 
2.3.5 Heat shock transformation of MSMEG_2196-pCR2.1 fragment into 
 E. coli DH5α cells 
To transform the MSMEG_2196-pCR2.1 fragment, E. coli DH5α calcium-
competent cells were used.  Standard heat shock transformation protocol was used as 
follow; 50 µL of E. coli DH5α cells were first thawed on ice for 5 mins, 280 µL of 
cold 0.1 M CaCl2 (Ajax Finechem Ltd., New Zealand) was added, this was then 
added to the ligation mixture and incubated on ice for 20 mins.   
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The cells were heat-shock treated at 42 ºC for 90 secs, then placed on ice for five 
mins, 280 µL of LB was added to the cells and incubated at 37 ºC for 1 hr.  The 
transformation mixture was centrifuged at 16,100 x g for 50 secs, excess supernatant 
was discarded leaving behind 100 µL for plating, and the cells were re-suspended into 
this.  The cells were then plated out onto LA Amp200, IPTG100, X-gal40 plates and left 
at 37 ºC for an overnight incubation. 
 
 
 
2.3.6 Midipreparation, purification, and stock culture of MSMEG_2196-pCR2.1  
plasmid DNA 
White colonies were picked from the overnight LA Amp200, IPTG100, X-gal40 
plates (from 2.3.5), and grown in 100 mL of LB containing Amp200 at 37 ºC 
overnight.  Midipreprations of plasmid DNA were carried out using the Invitrogen 
S.N.A.P™ midiprep kit (Invitroge, Auckland, New Zealand) following 
manufacturer’s instructions.  The Invitrogen PureLink™ PCR (Invitrogen, Auckland, 
New Zealand) purification kit was used to purify the plasmid following 
manufacturer’s instructions.  Stock cultures were prepared by adding 400 µL of 50 % 
glycerol to 600 µL of the cell culture and stored at -80 °C.   
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2.3.7   Plasmid digestion and gel purification of MSMEG_2196-pCR2.1   
The MSMEG_2196-pCR2.1 midipreparations were digested with Pac I NEB 
(BioLab, New Zealand) enzyme to check for insertion.  The digestion reaction 
contained 1 U/µL of Pac I (concentration at 10 U/µL), 1X NEB Buffer 1, and 20 µL 
of plasmid in 25 µL total reaction.  The digestion reactions were left at 37 ºC for 
overnight incubation, and were run on a 1 % agarose gel.  
For plasmid purification, the digested reaction was extracted from 1 % 
agarose gel and purified using Roche DNA purification kit (Roche, Auckland, New 
Zealand) following manufacturer’s instructions.  The purified digested fragment was 
ready to be ligated into pMind expression vector. 
 
 
 
2.3.8   Sequencing of MSMEG_2196-pCR2.1 fragment 
The digested plasmids (2.3.7) with the right size insert, were first quantified 
using either the Quanti-iT™ PicoGreen® (Invitrogen, Auckland, New Zealand) DNA 
quantification method, and/or the NanoDrop ND-1000 spectrophotometer (Global 
Science and Technology Ltd., Auckland, New Zealand) method following the 
manufacturer’s instructions.  For sample sequencing, the DNA concentrations of the 
midipreparations were adjusted to 300 ng/mL in a total volume of 14 µL, and sent to 
the Allan Wilson Centre in Palmerstorn North, New Zealand for sequencing. 
The chromatograms of the sequences were analyzed using Vector NTI 
software (Invitrogen, Auckland, New Zealand).   
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Corrections of the sequences were carried out in term of best fit such as length of 
sequence and identity, minimum number of mutations and clarity of the 
chromatogram, the best ones were then selected for further work. 
 
 
 
2.3.9   Ligation of MSMEG_2196 into the pMind expression plasmid 
Pac I digested and column purified pMind plasmid was provided by Shahista 
Nisa, Victoria University of Wellington, New Zealand.  The ligation reaction 
consisted of 1 µL of Pac I digested pMind, 1x ligation buffer 1 (BioLabs, Auckland, 
New Zealand), 3 µL of Pac I digested and gel purified MSMEG_2196-pCR2.1 
fragment, and 0.4 U/µL T4 DNA ligase in a total ligation volume of 10 µL.  The 
ligation reaction was incubated at 14 ºC overnight. 
MSMEG_2196-pMind ligation was transformed into E. coli DH5α cells as in 
2.3.5.  The only notable difference was that the cells were plated onto LA-Hyg50 
Kan50 plates and incubated at 37 ºC for 2 days. 
 
 
 
2.3.10 Insert and orientation check of MSMEG_2196 into pMind plasmid  
Single white colonies, from 2.3.9, were inoculated into 3 mL of LB broth 
containing Kan50 Hyg50 and incubated at 37 ºC overnight for midipreprations as in 
2.3.6.  To check for the insertion of MSMEG_2196 fragment into pMind, 
midipreparations were digested with 0.25 U/µL of Pac I, 1x NEB buffer 1 (BioLabs, 
Auckland, New Zealand), and 10 µL of plasmid in a 20 µL total reaction, the 
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digestion reaction was then run on a 1 % agarose gel.   Culture cells with insert in 
them were prepared and stored at -80 °C as in 2.3.6.  
To check for the orientation of MSMEG_2196 in pMind, a PCR was 
conducted using the TetRO primers, sequences in table 2.3.3.  Similar PCR 
conditions to that in 2.3.3 were followed except that 1 µL of each of the TetRO-F, 
Ms_2196/F1, and TetRO-R, Ms_2196/R1 primers were used, for the PCR regimen 
see table 2.3.1.  The PCR reaction was run on 1 % agarose gel and sent to the Allan 
Wilson Centre for sequencing as in 2.3.8.  From the chromatograms of the sequences, 
sense and antisense orientations were confirmed.      
 
 
 
 
Primer name Sequence  
TetRO-F GCTCTAGATCACGATTCGCTCGAGGTC 
TetRO-R CGGGATCCTGTCAGGATTCCACGATGAG 
 
Table 2.3.3:  pMind TetRO primers used to determine the sense and antisense orientations of 
MSMEG_2196 fragment in pMind.  
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2.3.11 Electroporation of MSMEG_2196-antisense/sense-pMind into M. 
smegmatis                                                                                                                                  
The MSMEG_2196-pMind midipreparations were prepared for 
electroporation as follow: MSMEG_2196-pMind midiprep was concentrated by 
spinning 200 µL in vacuum down to 30 µL.  The concentrated DNA was dialyzed on 
a nitrocellulose membrane, floating on 10 mL sterile distilled water for 30 mins then 
quantified using NanoDrop ND-1000 Spectrophotometer; DNA final concentration 
was 0.95 µg/µL.   
1, 5, and 10 µL of the dialyzed MSMEG_2196-pMind was electro-porated 
into 100 µL M. smegmatis mc2155 competent cells made up to 400 µL with 20 % 
glycerol.  The electroporation was carried out at 2.5 kV using Bio-Rad E. coli pulser 
electroporator (Bio-Rad, Auckland, New Zealand).  400 µL of LB was added to the 
electroporation mix, and the cells were left to recover at 37 °C overnight.  The cells 
were then plated onto LA-Hyg50 Kan50 plates and incubated at 37 °C for 1 week.  For 
control purposes, 10 µL of empty pMind plasmid was also transformed into M. 
smegmatis cells.    
M. smegmatis transformatn colonies were inoculated into 3 mL of LB-Hyg50 
Kan50 with 0.1 % Tween 80 and incubated at 37 °C for two days, after which -80 °C 
freezer stock were made as in 2.3.6. 
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2.4 Investigating growth effects of MSMEG_2196-antisense/sense 
 
2.4.1   Growth curves 
Growth curves were carried out in rich media using LB broth, and in nutrient-
limited media using Hartman de Bonts (HdeB) carbon (C¯), oxygen (O¯), 
phosphorous (P¯), and nitrogen (N¯) limited conditions,(appendix 5.2).  The cultures 
in HdeB O¯ limitation were grown in sealed (Suba seals) 250 mL flasks containing 
150 mL of HdeB media giving a headspace ratio of 1.67.  For OD600 sample readings, 
samples were taken by inverting the flask and inserting a fine 25-gauge needle 
through the Suba seal and extracting the sample by using 1 mL syringe (Bacton 
Dickinson, Auckland, New Zealand).   
M. smegmatis mc2155 wild type (M. smeg WT), M. smegmatis/pMind 
(Ms/pMind), M. smegmatis/pMind-2196-antisense (Ms/p2196 AS), and M. 
smegmatis/pMind-2196-sense (Ms/p2196 S) from -80 °C stock cultures were streaked 
out onto the appropriate agar plates and incubated at 37 °C for 3 days.  For starting 
culture, an inoculating loop of cells from these plates was initially placed into 50 mL 
of HdeB O⎯ media (without the seals) containing appropriate antibiotics, and LB 
broth (M. smegmatis mc2155) with no antibiotics and incubated overnight on a shaker 
at 37 °C and 200 rpm.   Next day the 50 mL culture was sub-cultured into 50 mL of 
LB broth, C⎯, O⎯, P⎯, and N⎯ HdeB limited media, with appropriate antibiotics to an 
initial OD600 absorbance of 0.1. 
The growth assays were conducted in triplicates for each strain, and three 
cultures contained tetracycline (Tc+) at a final concentration of 40 ng/mL, and three 
did not (Tc-) for all 4 strains.  All cultures were incubated at 37 °C, at 200 rpm and 
OD600 absorbance readings were taken every 90 mins for 12 hrs and then daily for up 
Chapter 2:  Materials and Methods 
 27
to two days. Experiments were repeated, where a significant difference (outside of 
standard error) was observed in any of the HdeB limited media culture. 
 
 
 
2.4.2  Determination of colony forming units 
Colony forming unit (CFU) counting was carried out on N⎯ cell culture 
where 1 mL of cells in stationary phase (24 hrs and 48 hrs) was removed from each 
culture for further analysis.  100 µL of these cells were serial diluted 10-1 to 10-5 in 
900 µL of 0.9 % sterile NaCl2 containing 0.1 % Tween 80.  The 10-3 to 10-5 dilutions 
were plated out onto LA plates (no antibiotics), and incubated for 3 days at 37 °C and 
the colonies obtained were counted.  
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2.5 Proteomic analysis of Ms/p2196 antisense grown under nitrogen 
limited conditions 
 
2.5.1 Protein of Ms/p2196 AS and Ms/pMind cells for one-dimension   (1D) and 
two-dimension (2D) gel analysis   
The Ms/p2196 AS and Ms/pMind Cells grown in HdeB N⎯ limited media (Tc+) 
were harvested at stationary phase (at time 1,800 mins) and cells were pelleted by 
centrifugation at 8,000 x g for 20 mins.  Each cell pellet (Ms/pMind and Ms/p2196 
AS) was re-suspended in 20 mL of sterile distilled water containing a cocktail of 
protease inhibitors (Complete, Roche, New Zealand). The solution was mixed, gently, 
by pipetting up-and-down for approximately 20 mins until the cells were mixed well 
in the sterile distilled water.    
Triton X-100 (Sigma-Aldrich, Auckland, New Zealand) was added to the re-
suspended pellets at a 2 % final concentration, and incubated with rocking on ice for 
1 hr. The solution was passed through a French press, Cell disrupture (Thermo 
Electron Corporation, Global Science and Technology Ltd., New Zealand) six to 
seven times until the solution was clear.  2 mL of the resulting lysate (from each cell 
sample solution) were aliquoted into eppendorf tubes and kept at -80 °C (sample A).  
To the remaining samples, the followings were added: 7 M urea (Gibco BRL, Life 
Technologies, New Zealand), 2 M thiourea (GE Healthcare, New Zealand); and 70 
mM DTT (Sigma-Aldrich, New Zealand).  The solution was incubated with rocking 
for 2 hrs at room temperature.  2 mL of this solution (sample B) were aliquoted into 
eppendorf tubes (from each cell sample solution) and kept at -80 °C.   
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The remaining cell lysates were kept at -80 °C.  1 mL of sample A and 1 mL of 
sample B were concentrated 5-fold using 5 kDa centrome centrifuge tubes (Millipore, 
Biolab Scientific, New Zealand). 
To check for the quality and quantity of protein in the cell lysates, 20 µL and 5 
µL of 5-fold concentrated sample A and sample B lysates, and 20 µL and 5 µL of 
non-concentrated sample A and B lysates were run on SDS-PAGE (Bio-Rad, New 
Zealand) using a 12 % acrylamide running SDS gel and 4 % acrylamide stacking gel.  
2-D Quanti Kit (Amersham, GE Healthcare, New Zealand) was used to quantify 
protein samples isolated from Ms/p2196 AS and Ms/pMind non-concentrated lysates. 
 
 
 
2.5.2 1D and 2D gel electrophoresis analysis of Ms/p2196 antisense expressing 
strain and Ms/pMind protein samples on pH 4-7 isoelectric focusing 
strips 
For 1D gel electrophoresis, 7 cm Immobiline DryStrips (GE Healthcare, New 
Zealand) with an immobilized pH gradient 4-7, were rehydrated overnight in 
rehydration buffer solution (7 M urea, 2 M thiourea, 2 % Triton X-100, 70 mM DTT, 
and 0.5 % IPG buffer pH 4-7) containing 100 µg of Ms/p2196 antisense and 
Ms/pMind non-concentrated protein sample in a final volume of 150 µL.  Ettan 
IPGphor Isoelectric focusing unit (Amersham Biosciences, GE Healthcare, New 
Zealand) was used to perform 1D gel electrophoresis following the manufacturer’s 
instructions, with the exception step 4 in which the running protocol was run at 4,000 
V.  
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The focused strips were equilibrated, prior to 2D gel electrophoresis, first, in 2 
mL of solution containing 1x LDS sample buffer (GE Healthcare, Auckland, New 
Zealand) and reducing agent (GE Healthcare, Auckland, New Zealand) in a 2:1 ratio, 
incubated at room temperature for 15 mins.  Then the strips were immersed into a 2 
mL solution containing 1x LDS sample buffer and 0.05 g of Iodoacetamide (GE 
Healthcare, New Zealand), and incubated at room temperature for 30 mins. 
The focused equilibrated strips were run on 2D gel electrophoresis using 
NuPAGE 4-12 % Bis-Tris precasted gels in a 1x MOPS SDS PAGE running buffer 
(GE Healthcare sciences, Auckland, New Zealand) containing 1 mL of NuPAGE 
antioxidant solution (Invitrogen, Auckland, New Zealand), gels were run at 200 V for 
1 hr.  The gels were removed from the casts and immersed into a fixative solution (50 
% ethanol [v/v], 2 % orthophosphoric acid [v/v], made up to the required volume with 
distilled water), then incubated at room temperature overnight.  Next day the gels 
were washed with sterile distilled water, for 30 mins 3 times.  The gels were stained 
with Colloidal Coomassie G-250 stain (17 % ammonium sulfate [w/v], 2 % 
orthophosphoric acid [v/v], 34 % methanol [v/v], made up to the required volume 
with sterile distilled water) for 2-3 days, after which the gels were washed with sterile 
distilled water 3-4 times, 1/2 hr each time, or until the water was clear. 
 
 
 
 
 
 
 
Chapter 2:  Materials and Methods 
 31
2.5.3   1D and 2D gel electrophoresis analysis of Ms/p2196 antisense expressing 
strain and Ms/pMind protein samples on pH 6-11 isoelectric focusing 
strips 
The Ms/p2196 antisense expressing strain and Ms/pMind protein samples 
were also run on pH 6-11 isoelectric focusing strips.  Similar protocol as in 3.5.2 was 
used except the following changes were made; the strips were rehydrated overnight in 
rehydration buffer (no protein sample) containing; 7 M urea, 2 M thiourea, 2 % 
CHAPS, 10 % isopropanol, 5 % glycerol, 1 % IPG buffer (pH 6-11), and 2.5 % DTT.  
Prior to use, the protein samples were precipitated using Albiochem Proteo Extract 
protein precipitation kit (GE Healthcare, Auckland, New Zealand) following the 
manufacturer’s instructions.  The dried protein pellets were then resuspended in 
sample buffer similar to the rehydrating buffer mentioned above.  1D gel 
electrophoresis was run using Ettan IPGphor Isoelectric focusing unit (Amersham 
Biosciences/GE Healthcare, Auckland, New Zealand), with cup loading following 
manufacturers protocol.  
 
 
 
2.5.4  Ms/p2196 antisense expressing strain and Ms/pMind 2D gel analysis 
The 2D gels were scanned using Personal Densitometer SI scanner (GE 
Healthcare, New Zealand).  For gel comparison and protein spot selections 
ImageMaster 2D Platinum 5.0 software (GE Healthcare/Amersham Biosciences, 
Auckland, New Zealand) was used, prior to the automated spot detection and 
matching function carried out by the ImageMaster software.  Manual specification of 
spots as landmarks for alignment of the gels was carried out.  
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The selected gel spots were quantified, in term of spot intensity, using ImageJ 
1.38x (Wayne Rasband, National Institute of Health, USA).  The spot analysis was 
carried out as follow: control (Ms/pMind) and the antisense expressing strain 
(Ms/p2196 AS) 2D gels were aligned next to each other.  The spots of interest 
labelled by ImageMaster were selected manually and the intensity of a spot was given 
in the form of a peak and the area under the peak gave a measurement called “pixel 
per area” (Figure 2.5.1). The obtained peak values were calculated as a ratio (AS/C 
when spot was up regulated in antisense and down regulated in control (C/AS when 
spot was down regulated in antisense but up-regulated in control). 
 
 
 
 
 
Figure 2.5.1:  2D gel spot intensity quantification using ImageJ software.  An example of 
Ms/pMind (left gel) and Ms/p2196 AS (right gel) spot intensity quantifications.  The spots (selected 
previously by ImageMaster software) were selected manually (1), this selection provides peaks which 
provide quantitative information (2).  The area under the peaks, expressed as “pixel per area” provides 
values that can be used to determine the relation of the expression fold of a spot on the gel (3). 
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Proteins were excised from 2D gels using a OneTouch Plus PDM 1.5 pipette 
(The gel Company); with TSP 1.5 mm diameter tips.  The excised proteins were 
placed in a 96 well plate, and overnight trypsin digestion was carried out using an 
Ettan Digester (Amersham Biosciences. Auckland, New Zealand), trypsin was added 
at a final concentration of 250 ng in a total volume of 50 µL of 20 mM ammonium 
bicarbonate.  The following day, the dried peptides were resuspended in 2 µL of 
matrix (α-cyano-4-hydroxycinnamic [CHCA] dissolved in 0.5 % trifluoroacetic acid 
[TFA]: acetonitrile [ACN] [V/V] in 50:50 dilution), after which they were spotted 
onto matrix-assisted laser desorption/ionization (MALDI) plate.  An external 
calibration was applied using calibration mixture II (Applied Biosciences, Auckland, 
New Zealand), 2 µL of this was added to 200 µL of CHCA matrix solution along with 
1 µL loaded onto the MALDI plate adjacent to the protein peptide spots (Figure 
2.5.2).  Using a Voyager DE-Pro (Applied Biosystems, Auckland, New Zealand) 
MALDI-Time of Flight Mass Spectrum (MALDI-TOF-MS) was employed to 
produce peptide mass fingerprinting.   
 
 
 
  
Figure 2.5.2:  Example of MALDI plate containing protein peptides of Ms/p2196 AS protein 
peptides (green) and external calibration sample (yellow).   Plate not drawn to scale. 
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2.5.5  Protein database search and protein identifications of Ms/p2196 
antisense and Ms/pMind peptide mass fingerprint 
For protein database searches, the Matrix Science software was used 
(http://www.matrixscience.com).  The Mascot search engine was selected, and the 
mass spectrums produced from MALDI-TOF-MS were run in the peptide mass 
fingerprint database 
http://www.matrixscience.com/cgi/search_form.pl?FORMVER=2&SEARCH=PMF .  
Within the Mascot mass fingerprint page, the following selections were made to 
obtain protein identifications; database: NCBInr, taxonomy: Actinobacteria (class), 
up to 1 missed cleavage was allowed, the fixed modification used was 
carbamidomethyl (C), and the peptide tolerance used was 50-100 ppm.  Identified 
proteins were significant if they had a probability greater than 66 % (significant 
threshold of P<0.05).  
 
 
 
2.6   Site directed mutagenesis of Mb1389c and MMEG_2196 
 
2.6.1  PCR of Mb1389c and MSMEG_2196 flanking region 
The reagent’s final concentrations used to amplify the flanking regions of 
Mb1389c and MSMEG_2196 were similar to that in 2.3.3.  The flanking region 
primers used were; C1/R4 (up-stream fragment) and F2/D2 (down-stream fragment) 
for Mb1389c; C11/R11 (up-stream fragment) and F13/R16 (down-stream fragment) 
for MSMEG_2196.  
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The flanking region’s PCR conditions are similar to that shown in table 2.3.1 
and the primers used for the mutagenesis work are listed in table 2.6.1.  Primers 
designed for both Mb1389c and MSMEG_2196 had Pac I digest sites (appropriate to 
ligate into pUHA778 knock out vector).   
 
 
 
Primer 
name 
Enzyme 
site 
Sequence  
Mb1389c C1 Pac I CTAGTTAATTAATCGCTCGATGCGGGCATCGAT 
Mb1389c R4  TAACGCGGGTCCGCGGTGTCGTTGCACATCTCGGATGCTA 
Mb1389c F2  AACGACACCGCGGACCCGGCGTTATCTTGA 
Mb1389c D2 Pac I CTAGTTAATTAAAGTTGCGTGCAAGCAGCGG 
Ms_2196 C11 Pac I CTAGTTAATTAAAATGCAGGCACTACACACCGCGG 
Ms_2196 R11  CATGCGAGGCGCAGCACTTGAGCTCAGCCCTGT 
Ms_2196 F13  GGGCTGAGCTCAAGTGCTGCGCCTCGCATGTGAGTGCGG 
Ms_2196 R16 Pac I CTAGTTAATTAATCGTGGCGGACCAGGATCCGT 
 
Table 2.6.1:  Mb1389c and MSMEG_2196 flanking region and overlap PCR primers.  This table 
lists the primers used to amplify the flanking regions and overlap PCR of Mb1389c and 
MSMEG_2196.  Nucleotides in bold letters represent the enzyme site.  
 
 
 
2.6.2 Mb1389c Overlap PCR 
Overlap PCR, as described previously [56], and outlined in Sambrook and 
Russell (Volume II 13.36-13.39) [115] was used to join the upstream and downstream 
fragments of Mb1389c flanking region to create the Mb1389c deletion fragment.   
The reagent’s final concentrations were 0.2 mM dNTPs, 2.5 mM MgSO4, 0.8 
µM of each primer (Mb1389c C1/D2), 1x PCR reaction buffer, and 0.05 U/µL 
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Platinum Taq polymerase.  The DNA template was made up of 0.5 µg of each 
flanking region in a 50 µL reaction.  The C1/D2 overlap PCR condition for Mb1389c 
is listed in table 2.6.2. 
 
 
 
Steps  Temperature 
(°C) 
Time 
(mins) 
1. Heating 104 4.0 
2. Denaturation 94 1.0 
3. Annealing 45 1.0 
4. Extension  68 2.0 
5. Steps 2-4 repeat 40 times   
6. Extension  68 10 
 
Table 2.6.2:  Mb1389c C1/D2 overlap PCR condition.  This table lists the PCR condition used to 
amplify the overlap fragment of Mb1389c.  
 
 
 
2.6.3 MSMEG_2196 overlap PCR 
For the production of the MSMEG_2196 deletion fragment, the initial protocol 
used was similar to that in 2.6.2; however, after a few attempts with no success a new 
approach was applied as described previously [23].  The reagent final concentrations 
were; 0.16 mM dNTPs, the primers Ms_2196 C11 and R16 each at 0.32 µM, 1.6 mM 
of MgSO4, 1X PCR reaction buffer, 0.04 U/µL of Platinum Taq polymerase, DMSO 
was also used at 2.5 %.  
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The template DNA was made up of 0.2 ug of each flanking region in a 31 µL 
total reaction.  The PCR protocol involves pausing the 68 ºC extension step (half way 
through the step), and then adding the up-stream and down-stream primers, in this 
case the C11/R16 primers, and then continuing the cycle. Table 2.6.3 lists the overlap 
PCR conditions used for the MSMEG_2196 C11/R16 PCR. 
 
 
 
Step  Temperature 
(°C) 
Time (mins) 
1.  Heating  94 2.0 
2.  Denaturation 94 0.30 
3.  Annealing 55 0.30 
4.  Extension 68 1.0 
5.  Repeat step 2-4 three times. Pause third time 
of extension step at 30 secs then add C11/R16 
primer.  Continue cycle.  
  
6.  Denaturation 94 0.30 
7.  Annealing 56 0.30 
8.  Extension 68 5.0 
9. Repeat steps 6-8 x25   
10.  Extension 68 10.0 
 
Table 2.6.3:  PCR conditions used to amplify the MSMEG_2196 overlap fragment. 
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2.6.4 Preparations of Mb1389c and MSMEG_2196 overlap PCR fragments 
for ligation into pUHA778 knock-out vector. 
Similar protocols to those in steps 2.3.4-2.3.8 were followed for Mb1389c 
and MSMEG_2196 mutant fragment preparations.  One notable change was that the 
Mb1389c- /MSMEG_2196-overlap PCR fragments were ligated into pGEM-T Easy 
cloning vector.   
 
 
 
2.6.5   pUHA778 knock-out plasmid preparation 
DNA of the pUHA778 knock out plasmid was supplied from AgResearch 
(Wallaceville, New Zealand).  The isolation of this plasmid was prepared as follow:  
2 µL of the pUHA778 DNA was transformed in 250 µL of E. coli DH5α cells 
resuspended in 0.1 M CaCl2.  The cells were plated onto LA-Hyg100 plates and 
incubated at 37 ºC overnight.  Colonies from these plates were inoculated for 
preparation of plasmid as in 2.3.6.  To check for the presence of a single Pac I site, 
the plasmid midipreperations were digested with 0.3 U/µL of Pac I enzyme 
(concentration at 10 U/µL), 1X NEB Buffer 1, and 21.5 µL of plasmid in a 30 µL 
total reaction.  Roche DNA gel purification kit was used to purify the Pac I-digested 
pUHA778 plasmid, following the manufacturer’s instructions.  5 µL of the gel 
purified pUHA778 plasmid was run on a 1 % low electroendosmosis agarose gel to 
check for its presence and its quantity.  
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2.6.6   Ligation of Mb1389c- and MSMEG_2196-overlap fragments into 
pUHA778 and transformation into E. coli DH5α cells 
For the ligation of the Mb1389c and MSMEG_2196 overlap fragments into 
pUHA778, the ligation reaction contained 2.5 µL of Pac I-digested pUHA778 
plasmid, 20 µL of Pac I-digested Mb1389c-/MSMEG_2196-overlap fragment, 1X 
ligation buffer 1 (BioLabs, New Zealand), and 0.15 U/µL of T4 DNA ligase in a 60 
µL total reaction.  The ligation reaction was incubated overnight at 4 °C. 
The Mb1389c-/MSMEG_2196-pUHA778-ligated overlap fragments were 
transformed into E. coli DH5α cells as described previously in 2.3.5.  The 
transformed cells were plated onto LA-Hyg50 Amp100 plates and incubated overnight 
at 37 °C. 
 
 
 
2.6.7 Mb1389c-/MSMEG_2196-overlap insert check in pUHA778 vector and 
preparation for electroporation 
Mb1389c-/MSMEG_2196-pUHA778 colonies from the transformed cells in 
2.6.6 were inoculated into 100 mL LB-Hyg50 Amp100 for preparation of plasmids as 
in 2.3.6.  Pac I enzyme was used, as in 2.3.7 
 The Mb1389c/pUHA778 deletion fragment midipreparation was concentrated  
6-fold by spinning 320 µL in a speed vacuum for 5 hrs at 37 °C and resuspended in a 
final volume of 50 µL.  The concentrated DNA was then dialyzed on a nitrocellulose 
membrane, floating on 60 mL sterile distilled water for 30 mins.  The dialyzed DNA 
was quantified using a NanoDrop ND-1000 spectrophotometer. The final 
concentration of the DNA was 0.53 µg/µL.  This DNA was sent to AgResearch, 
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Wallaceville, New Zealand PC3 laboratories to be electroporated into M. bovis.  For 
electroporation of Mb1389c/pUHA778 into M. bovis WAg203 see appendix 5.3. 
 MSMEG_2196/pUHA778 overlap fragment midipreparation was 
concentrated 6-fold by spinning 200 µL in vacuum down to 30 µL; this concentrated 
DNA was dialyzed, quantified, and denatured as described above.  The DNA final 
concentration was 1 µg/µL.   
 
 
 
2.6.8   PCR and Southern blot analysis for single homologous recombination of 
Mb1389c/pUHA778 in M. bovis 
Genomic DNA preparation was carried out on M. bovis-pUHA778/Mb1389c 
heat-killed colonies, obtained from AgResearch, as in 2.3.1 except the pellets were 
resuspended in 100 µL of sterile-distilled water, and run on a 1 % agarose gel to 
check for DNA quality and quantity.  Initially, PCR was used to check for a single 
homologous recombination. The primer sequences are listed in table 2.6.4.  The same 
PCR set up described in 2.3.2 was used except a 50 µL final volume was used and 5 
µL of gDNA was added.  PCR conditions were set up as in table 2.3.1, except an 
annealing temperature gradient (45-60 °C) was used.   
Southern blot was also used to check for the presence of single and/or double 
homologous recombinants of Mb1389c in M. bovis.  Mb1389c C1/R4 primers (Table 
2.6.1) were used to amplify a DNA fragment for use as the hybridization probe.  
gDNA preparations of heat killed M. bovis-pUHA778-Mb1389c colonies were 
RNAse treated and then digested with Bgl II (BioLabs, Auckland, New Zealand).   
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The digestion reaction’s final concentrations were; 1X NEB buffer 3, 1.75 U/ml of 
Bgl II enzyme, 25 µL of gDNA in a total volume of 35 µL.   The digestion reaction 
was incubated at 37 °C overnight, and run on a 0.8 % agarose gel at 30 V.  For 
control purposes, wild type Mb1389c, and wild type MSMEG_2196 gDNA were 
digested with Bgl II enzyme in the same manner except that 5 µL of gDNA was 
added in a total volume of 10 µL digestion reaction. α-³²P-dCTP (Amersham/GE 
Healthcare, Auckland, New Zealand) was used as the radiolabel for hybridizations.  
For a full detailed protocol of Southern blot, refer to appendix 5.4.    
The membranes were exposed to film for 2-3 days after which the films were 
developed and fixed using Kodak processing chemicals for autoradiography films 
GBX developer and fixer (Sigma-Aldrich, New Zealand).   
 
 
 
Primer name Sequence 
DF1 AAGGCCATCAACGACTACCTG 
DF2 AGCGTCACCCCATTGCGC 
DF3 AGGCTACATGAGGAAATG 
DR1 CGGACCAATGCCTCGGCT 
DR2 TACCAGTAGATGCTGGTG 
DR3 CATTCGAGACCATATTCG 
 
Table 2.6.4:  M. bovis p1389Δ primers for analysis of M. bovis recombinants.  This table lists the 
primers used in PCR to screen for recombinants of Mb1389c in M. bovis.   
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2.6.9 MSMEG_2196/pUHA778 electroporation into M. smegmatis 
1, 5, and 10 µL of dialyzed MSMEG_2196/pUHA778 DNA sample, from 
2.6.7, was electro-porated into 100 µL of M. smegmatis mc2155 competent cells made 
up to 400 µL with 20 % glycerol.  The electroporation was carried out at 2.5 kV using 
a Bio-Rad E. coli pulser electroporator (BioRad, Auckland, New Zealand).  400 µL of 
LB was added to the electroporation mix, and the cells were left to recover at 37 °C 
overnight.  The next day, the cells were plated onto LA-Hyg50 Amp50 plates and 
incubated at 37 °C for 1 week.  For control purposes, 10 µL of empty pUHA778 
plasmid was also transformed into M. smegmatis cells in the same manner.  
 
 
 
2.6.10 PCR and Southern blot analysis of M. smegmatis/MSMEG_2196-
pUHA778 recombinants  
Colonies (2.6.9) were picked and inoculated into 3 mL of LB broth containing 
Hyg50 Amp50, 0.1 % Tween 80, and were incubated at 37 ºC with shaking at 200 rpm 
for 2 days after which gDNA was prepared as described in 2.3.1. 
To check for the presence of a mutation in MSMEG_2196 knock-out in  
M. smegmatis, PCR primers used to amplify the flanking region of MSMEG_2196, 
table 2.6.1, were used; as well as new primers shown in table 2.6.5.  The PCR 
screening was carried out on M. smegmatis-pUHA778-MSMEG_2196 gDNA 
preparations and/or single colonies.  PCR conditions used for PCR were set up as in 
table 2.3.1, and the PCR conditions for single colony screening were conducted as in 
table 2.3.1.  
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Southern blot analysis was also used to check for the presence of single 
homologous recombination and/or gene knockout.  Southern blotting was carried out 
in the same manner as in 2.6.9, however MSMEG_2196 F4/R4 amplified fragment 
was used as the probe.  Econ I (BioLabs, Auckland, New Zealand) enzyme was used 
to digest gDNA of M. smegmatis/MSMEG_2202-pUHA778, using the protocol 
described in 2.6.8 except that 1X NEB buffer 4 (BioLabs, New Zealand) was used.  
M. smegmatis wild type and M. bovis gDNA was used as a positive and negative 
control, respectively.  
 
 
 
Primer name sequence 
Ms_2196 F61 GAGTCGGCCGCACTCTACGAG 
Ms_2196 R61 AAGCGCCAGCAGGTTCAGCAG 
Ms_2196 F62 GTGACGACGACCGATCGCGAC 
Ms-2196R62 CCTTGACGTAGAGGTCGCCTG 
Ms_2196 F4 CTGAAGGCGATCAACGACTACCTG 
Ms_2196 R4 CCAGCGGACCAGCGCTTCTGCCGC 
 
Table 2.6.5- PCR primers used to check for MSMEG_2196 mutants in M. smegmatis.  
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3 Results 
 
3.1   Bioinformatics of cyclic-di-GMP in mycobacteria   
 
3.1.1  Cyclic di-GMP protein encoded by the M. tuberculosis, M. bovis, and M. 
smegmatis genome 
Since proteins involved in the synthesis of cyclic di-GMP contain GGDEF 
domain, the M. tuberculosis genome was searched for GGDEF domain using 
TIGRFAMs database (see Materials and Methods section 2.2).  Rv1354c, in the 
genome of M. tuberculosis, was found to be the only gene containing GGDEF-EAL-
GAF domains adjacent to each other (Fig. 3.1.1 A).  Rv1354c is annotated as a 
“conserved hypothetical protein”, consisting of 623 amino acids.  It has a predicted 
gene length of 1872 bp.  The corresponding ortholog of Rv1354c in M. bovis is 
Mb1389c and in M. smegmatis is MSMEG_2196, these two had the highest score and 
sequence alignment to Rv1354c (Table 3.1.1).  Refer to appendix 5.5 for gene 
sequence alignment of the three proteins.  Pfam domains structure of Rv1354c was 
obtained from the annotation database of TIGRFAM (Fig. 3.1.1 A), and a table was 
given by the database which shows nucleotide boundaries for each of the domain 
(Fig. 3.1.1 B).   
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Gene  Score Amino acid identity E-value 
Mb1389c 9360 1872/1872 (100%) 0 
MSMEG_2196 3776 1272/1855 (68%) 7.2e-165
 
Table 3.1.1:  Score and amino acid percentage identity of M. bovis and M. smegmatis c-di-GMP 
gene against M. tuberculosis Rv1354c.   
  
 
 
 
Figure 3.1.1:  Pfam domain search result of GGDEF domain in M. tuberculosis Rv1354c genome.  
(A) M. tuberculosis Rv1354c domain structure.  (B) Boundary of each of the domain showing the start 
and end of the nucleotide sequence. 
 
 
 
3.1.2 Gene and protein sequences of Mb1389c and MSMEG_2196 
The orthologous of Rv1354c gene sequence in M. bovis and M. smegmatis 
were derived from TIGRFAM database with 600 bp spanning each end of the 
sequence.  The protein sequences were obtained using the TIGRFAM database.  The 
protein and the DNA sequences are in appendix 5.6. 
 
 
(A) 
(B) 
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3.2  Altered expression of MSMEG_2196 in M. smegmatis 
 
3.2.1 Amplification of MSMEG_2196 
Ms_2196 F1 and R1 primers (Table 2.3.2) were used to amplify 
MSMEG_2196.  The PCR products were run on a 1 % agarose gel (Figure 3.2.1).  
The amplified product of MSMEG_2196 is between 2 - 1.6 Kbp, this is shown in lane 
5.  This band was cut and gel purified.   
 
 
 
 
Figure 3.2.1:  PCR amplification of MSMEG_2196.  Lane 1 contains 1 Kb+ ladder (Invitrogen, New 
Zealand), lane 2 negative control (no gDNA), and lane 3 positive control (Ms_2196 F3/R3).  Lane 4 
contains PCR of MSMEG_2196 fragment amplified with Ms_2196 F1/R1 primers no DMSO; this 
amplification gave unspecific product.  Lane 5 contains MSMEG_2196 fragment amplified using 
Ms_2196 F1/R1 primers  
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3.2.2 Cloning of the MSMEG_2196 gene into pCR2.1 vector 
The amplified product of MSMEG_2196 was ligated into pCR2.1 cloning 
vector and then transformed into E. coli DH5α cells.  To check for MSMEG_2196 
insert in the cloning vector, the colonies obtained from the transformation were 
digested with Pac I enzyme and run on 1 % agarose gel (Figure 3.2.2).  Recombinant 
plasmids with MSMEG_2196 insert were sequenced to double check for the insert. 
 
 
 
 
Figure 3.2.2:  MSMEG_2196-pCR2.1 Pac I digested plasmids.  Lanes 1 and 12 contain 1 Kb+ 
marker (Invitrogen, New Zealand).  Lanes 2-11 contain Pac I digested MSMEG_2196-pCR2.1 
recombinant plasmids run on 1 % agarose gel to check for MSMEG_2196 insert.  Inserts are present in 
lanes 4-8 and lane 10 (size of band is between 2 – 1.6 Kbp).   
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3.2.3  Ligation of MSMEG_2196 into pMind and check for inserts 
Pac I digested MSMEG_2196 fragment was ligated into Pac I digested and 
purified pMind plasmid.  MSMEG_2196-pMind was transformed into E. coli DH5α 
cells. Recombinant plasmids resulting from the transformations were digested with 
Pac I enzyme, to check for the inserts, and were run on a 1 % agarose gel (Figure 
3.2.3). 
The expression of a gene in pMind is induced by the influence of 
tetracycline.  In the absence of tetracycline, the regulator tetR represses expression 
from the tetO operator which results in gene repression.  In the presence of 
tetracycline, repression on the expression of tetO operator (caused by the tetR 
regulator) is lifted leading to the expression of the gene that is in front of the tetO 
operator, in this case MSMEG_2196.   
 
 
 
 
Figure 3.2.3:  1 % agarose gel of MSMEG_2196-pMind recombinant plasmids digested with Pac 
I enzyme.  Lanes 1 and 25 contains 1 Kb+ marker (Invitrogen, New Zealand).  23 recombinant 
plasmids of MSMEG_2196-pMind digested with Pac I enzyme were run on agarose gel (lanes 2-24).  
MSMEG_2196 inserts are in lanes 3, 7, 9-11, 13-14, 18, 21-22, and lane 24, the fragment size is 
between 2 – 1.6 Kbp.   
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3.2.4 Checking the orientation of the MSMEG_2196 gene in pMind vector  
To check the orientations of the MSMEG_2196 gene (antisense or sense) in 
pMind, PCR was carried out on single colonies obtained from transformation using 
primers shown in table 2.3.3.   
A sense fragment is produced if PCR products are yielded using TetRO-F and 
Ms_2196 R1 primers (Figure 3.2.4 A).  An antisense fragment will be generated if 
PCR products are produced using TetRO-F and Ms_2196 F1 primers (Figure 3.2.4 
B).  In both cases, the PCR product is ~2 kbp.  
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 (A)                                                                   (B) 
                                                                                    
     
 
 
 
 
Figure 3.2.4:  Possible orientations of MSMEG_2196 in pMind.  Depending on the orientation of 
MSMEG_2196 fragment ligated into the pMind vector.  In the above figure (A), a PCR product will be 
generated if fragment is in the sense orientation using TetRO-F and Ms_2196 R1 primers giving a PCR 
product of ~ 2 kbp (in this case there will be no PCR product using Ms_2196 F1 and TetRO-F 
primers).  In figure (B), a PCR product will be generated in the antisense orientation using TetRO-F 
and Ms_2196 F1 primers once again giving a fragment size of ~ 2 kbp (using TetRO-F and Ms_2196 
R1 will produce no product in this case). 
 
 
 
 
The forward primer, TetRO-F was used with Ms_2196 F1 or the R1 primers 
(Table 2.3.2).  PCR was run on 1 % agarose gel (Figure 3.2.5, and Table 3.2.1), and 
from this PCR, MSMEG_2196 antisense and sense samples were determined. 
 
 
 
pMind 
tetO 
MSMEG_2196 MSMEG_2196 
pMind 
tetO 
R1 (PacI) 
F1 (PacI) 
MSMEG_2196 MSMEG_2196 
R1 (PacI)  
tetR 
 
F1 (PacI) 
tetR 
TetRO-F   
TetRO-F  
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Figure 3.2.5:  1 % agarose gel of antisense and sense PCR of MSMEG_2196-pMind.  PCR was 
carried out on 11 single colonies obtained from MSMEG_2196-pMind transformation.  The PCR was 
run using the TetRO-F primer and Ms_2196 F1 or R1 primers.  For each of the 11 single colonies, two 
PCR reactions were run; one reaction with TetRO-F/Ms_2196 F1 primers, and the other using TetRO-
F/Ms_2196 R1 primers.  See table 3.2.1. 
 
 
 
After determining the sense and antisense orientation in the 
MSMEG_2196/pMind transformants, colonies were picked and grown into 50 mL of 
LB broth containing Hyg50 kan50 and incubated at 37 ºC for overnight.  From these  
-80 º C stocks were made.  A sense and antisense sample was chosen for the growth 
assays experiments.  Table 3.2.1 lists all of the amplified products obtained from the 
MSMEG_2196/pMind PCR conducted to determine the orientation of MSMEG_2196 
gene in pMind.  
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Gel lane 
number 
Colony 
number*  
Primers PCR 
products
Antisens/Sense 
4 SC1 TetRO-F/Ms_2196 F1 Yes  Antisense  
5 SC1 TetRO-F/Ms_2196 R1 No  Antisense  
6 SC2 TetRO-F/Ms_2196 F1 No  Sense  
7 SC2 TetRO-F/Ms_2196 R1 Yes  Sense  
8 SC3 TetRO-F/Ms_2196 F1 Yes  Senese  
9 SC3 TetRO-F/Ms_2196 R1 No  Sense  
10 SC4 TetRO-F/Ms_2196 F1 Yes  Antisense  
11 SC4 TetRO-F/Ms_2196 R1 No  Antisense  
12 SC5 TetRO-F/Ms_2196 F1 Yes  Antisense  
13 SC5 TetRO-F/Ms_2196 R1 No  Antisense  
14 SC6 TetRO-F/Ms_2196 F1 No  Sense  
15 SC6 TetRO-F/Ms_2196 R1 Yes  Sense  
16 SC7 TetRO-F/Ms_2196 F1 No  Sense  
17 SC7 TetRO-F/Ms_2196 R1 Yes  Sense  
18 SC8 TetRO-F/Ms_2196 F1 Yes  Antisense  
19 SC8 TetRO-F/Ms_2196 R1 No  Antisense  
20 SC9 TetRO-F/Ms_2196 F1 No  PCR did not work 
21 SC9 TetRO-F/Ms_2196 R1 No  PCR did not work 
22 SC10 TetRO-F Ms_2196 F1 No  Sense  
23 SC10 TetRO-F/Ms_2196 R1 Yes  Sense  
24 SC11 TetRO-F Ms_2196 F1 No  PCR did not work 
 
Table 3.2.1:  Antisense and sense PCR results of MSMEG_2196-pMind.  The results of the 1 % 
agarose gel shown in figure 3.2.5.  It demonstrates which of the samples, run on the gel, contained the 
gene in the sense or antisense orientation.  
 
* SC = single colony.  
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3.3 Growth assays of MSMEG_2196-pMind antisense/sense culture 
 
3.3.1 Nutrient rich growth assay of MSMEG_2196-pMind antisense/sense 
 The four strains: M. Smeg WT, Ms/pMind, Ms/p2196 S, and Ms/p2196 AS 
were grown in LB broth.  This nutrient rich assay was used as a control to compare 
the growth of the four strains to that of the nutrient limited-growth assays and to see if 
either antisense and/or sense strain in rich media alone could have any effects on 
growth under nutrient-rich conditions.  The experiment was conducted in triplicate, 
with 0 ng/mL, and 40 ng/mL of Tc.  OD600 absorbance readings were taken every 90 
mins for the first 11 hrs and then every 3 hrs the next day.  The growth curves in the 
presence of 0 ng/mL and 40 ng/mL of Tc are shown in figure 3.3.1 A and B, and 
specific growth rates and doubling times were also calculated and these are shown in 
table 3.3.1.   
Standard deviation of the mean, also known as standard error, was calculated 
using Microsoft Excel.  The mean of the triplicates was calculated and from the mean, 
standard deviation was obtained using Excel.  The standard error was calculated by 
dividing standard deviation by the square root of the number of measurements, in this 
case by 3 .  From the growth curve, the specific growth rates and doubling times 
clearly show that the growth of all four cultures was not affected in either the absence 
or presence of Tc in the rich LB broth media. 
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(A) 
 
(B) 
 
Figure 3.3.1:  Growth curve of M. smegmatis WT, Ms/pMind, Ms/p2196 sense, and Ms/p2196 
antisense grown in LB broth rich media.  The four strains were grown in LB broth containing either 
0 ng/mL (A), or 40 ng/mL (B) of Tc.  On the first day, the OD600 readings of the assay were taken 
every 90 mins, then every 3 hrs there after.  The results were plotted on a semi-log graph. 
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Table 3.3.1:   Specific growth rates and doubling times for nutrient rich (LB broth) growth 
assay.  This table lists the growth rates and doubling time of the four cultures grown in the LB broth 
rich media in the presence and absence of Tc. 
 
 
 
3.3.2   Carbon limited growth assay of MSMEG_2196-pMind antisense/sense 
M. smegmatis WT, Ms/pMind, Ms/p2196 S, and Ms/2196 AS were grown in 
Hartman-de Bont (HdeB) carbon limited (C¯) media supplemented with 0.08 % 
(vol/vol) glycerol. Tc was added to the culture at concentrations of 0 ng/mL and 40 
ng/mL.  The cultures were grown in triplicate, and as with the rich media, the OD600 
readings were taken every 90 mins for the first 11 hrs then 3 hrs daily for 2 days.  
Standard error was calculated as described in 3.3.1.  Both cultures (Tc-, Tc+) grown 
in the carbon-limited media had no growth effect in the exponential- and stationary-
phase (Figure 3.3.2). However, cultures grown in the presence of Tc grew at a slower 
rate. Specific growth rates and doubling times between the four cultures did not vary 
significantly, i.e. no difference outside the standard error values (Table 3.3.2).   
 
 
M. smegmatis  
strian 
Tc  Log-phase specific growth 
rate (min-1) 
Doubling time 
(mins) 
M. smeg WT  - 0.003192 (± 0.0000194) 217 (± 1.32) 
M. smeg WT  + 0.002610 (± 0.0000363) 266 (± 3.70) 
Ms/pMind  - 0.002447 (± 0.0004650) 283 (± 5.26) 
Ms/pMind  + 0.002107 (± 0.0000430) 329 (± 6.71) 
Ms/p2196 S  - 0.002503 (± 0.0000844) 277 (± 9.34) 
Ms/p2196 S + 0.001875 (± 0.0000474) 370 (± 9.34) 
Ms/p2196 AS  - 0.002620 (± 0.0000589) 265 (± 5.95) 
Ms/p2196 AS  + 0.002698 (± 0.0000471) 257 (± 4.48)  
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 (B) 
 
Figure 3.3.2:  Growth curve of M. smegmatis WT, Ms/pMind, Ms/p2196 S, and Ms/p2196 AS 
grown in HdeB C¯ limited media.  This graph illustrates the four strains grown in HdeB C¯ limited 
media containing either 0 ng/mL (A), or 40 ng/mL (B) of Tc.  On the first day, the OD600 readings of 
the assays were taken every 90 mins, then every 3 hrs there after, up to 2 days.  Overall, outside of 
standard errors, there was no significant difference (outside of standard errors) or growth change 
between the four cultures grown in either the presence or absence of Tc.  The results were plotted on a 
semi-log graph. 
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Table 3.3.2:   Specific growth rates and doubling times for C¯ limited growth assay in HdeB 
media.  This table lists the growth rates and doubling time of the four cultures grown in the carbon 
limited HdeB media in the presence/absence of Tc.  Overall, there are no significant differences 
(outside of standard errors) in either the growth rate or doubling time in all four cultures. 
 
 
 
3.3.3 Oxygen limited growth assay of MSMEG_2196-pMind antisense/sense 
M. smegmatis WT, Ms/pMind, Ms/p2196 S, and Ms/p2196 AS were grown in 
150 mL of HdeB oxygen (O¯) limited media (see 2.4.1).  The four cultures were 
grown in triplicate with 0 ng/mL and 40 ng/mL of Tc. OD600 absorbance readings 
were taken every 90 mins for the first 10 hrs then every 3 hrs daily for 2 days (Figure 
3.3.3).  Standard errors were calculated as described in 3.3.1.  The specific growth 
rates and doubling times of the oxygen limited assay are shown in table 3.3.3.  In the 
presence of Tc, the growth of Ms/p2196 antisense was slightly affected after 3 hr of 
growth (Figure 3.3.3).  This slight change is not significant as shown by the specific 
growth rate and doubling time (not significant outside of standard errors) calculated 
(Table 3.3.3). 
 
 
M. smegmatis 
strain 
Tc Log-phase specific growth 
rate (min-1) 
Doubling time 
(mins) 
M. smeg WT  - 0.002810 (± 0.000303) 247 (± 26.56) 
M. smeg WT  + 0.002655 (± 0.000220) 261 (± 21.62) 
Ms/pMind  - 0.002962 (± 0.000049) 234 (± 3.87) 
Ms/pMind  + 0.002525 (± 0.000055) 274 (± 5.97) 
Ms/p2196 S - 0.002708 (± 0.000182) 256 (± 17.20) 
Ms/p2196 S + 0.002250 (± 0.000090) 308 (± 12.32) 
Ms/p2196 AS - 0.002238 (± 0.000054) 310 (± 7.48) 
Ms/p2196 AS + 0.001916 (± 0.000046) 362 (± 8.69) 
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 (B) 
 
Figure 3.3.3:  Growth curve of M. smegmatis WT, Ms/pMind, Ms/p2196 S, and Ms/p2196 AS 
grown in HdeB O¯ limited media.  This graph shows the four strains grown in HdeB O¯ limited 
media containing either 0 ng/mL (A), or 40 ng/mL (B) of Tc.  On the first day, the OD600 readings of 
the assays were taken every 90 mins, then every 3 hrs there after, up to 2 days.  The Ms/p2196 
antisense strain, in the presence of Tc, grew slightly at a lower rate at stationary-phase compared to the 
three other strains.  However, from the calculated specific growth rates and doubling times this slight 
change is not significant.  These results were plotted on a semi-log graph. 
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Table 3.3.3:  Specific growth rates and doubling times for O¯ limited growth assay in HdeB 
media.  This table lists the growth rates and doubling times of the four cultures grown in the O¯ 
limited HdeB media in the presence/absence of Tc.  Overall, there was no significant difference 
(outside of standard errors) in either the growth rate or doubling times in all four cultures. 
 
 
 
3.3.4 Phosphorous limited growth assay of MSMEG_2196-pMind 
antisense/sense culture. 
 The four cultures, M. smegmatis WT, Ms/pMind, Ms/p2196 S, and Ms/p2196 
AS, were grown in HdeB phosphorous limited (P¯) media.  The phosphorous was 
reduced 100 mM to 0.1 mM.  Glycerol was added at a final concentration of 0.2 %. 
Standard errors of the growth curve were generated as described in 3.3.1.  The four 
cultures were grown in triplicate with 0 ng/mL and 40 ng/mL of TC.  OD600 
absorbance readings were taken every 90 mins for the first 10 hrs then every 3 hrs the 
next day.   
 
 
M. smegmatis 
strain 
Tc Log-phase specific growth 
rate (min-1) 
Doubling time 
(mins) 
M. smeg WT  - 0.003522 (± 0.000604) 197 (± 33.74) 
M. smeg WT  + 0.003860 (± 0.000721) 180 (± 33.60) 
Ms/pMind - 0.004055 (± 0.000710) 171 (± 29.95) 
Ms/pMind  + 0.003406 (± 0.001012) 203 (± 60.24)  
Ms/p2196 S  - 0.003001 (± 0.001235) 231 (± 95.06) 
Ms/p2196 S  + 0.002830 (± 0.001041) 245 (± 90.07) 
Ms/p2196 AS  - 0.003501 (± 0.000532) 198 (± 30.09)  
Ms/p2196 AS  + 0.003076 (± 0.000636) 226 (± 54.96) 
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The four cultures grown in the phosphorous-limited media showed no 
significant growth effect difference (outside of standard errors) in either the presence 
or absence of Tc (Figure 3.3.4).  One notable difference is that at exponential-phase 
(in the presence of Tc), all four cultures grew at a slower rate (these cultures have 
high doubling times compared to doubling times of culture with no Tc).  This growth 
effect could be due to the phosphorous-limited media, compared to the four strains 
grown in carbon-, or oxygen-limited media.  This slight change observed is not 
significant enough (outside of standard errors) to conclude that the over- and/or 
down-expression of MSMEG_2196 in M. smegmatis are affected because the changes 
seen in the growth behaviour is observed in all four cultures.  
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(B) 
 
Figure 3.3.4:  Growth curve of M. smegmatis WT, Ms/pMind, Ms/p2196 S, and Ms/p2196 AS 
grown in HdeB P¯ limited media.  This graph illustrates the growth of the four strains grown in 
HdeB P¯ limited media containing either 0 ng/mL (A), or 40 ng/mL (B) of Tc.  On the first day, the 
OD600 readings of the assays were taken every 90 mins, then every 3 hrs the next day.  Overall, outside 
of standard errors, there is no significant difference or changes between the growth of the four cultures 
in either the presence and absence of Tc.  The results were plotted on a semi-log graph.  
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Table 3.3.4:  Specific growth rates and doubling times for P¯ limited growth assay in HdeB 
media.  Growth rates and doubling time of the four cultures grown in the P¯ limited HdeB media in 
the presence/absence of Tc.  Overall, the four cultures grown in phosphorous-limited media grew at a 
slower rate compared to carbon-, or oxygen-limited growth assays.  The four strains grown in the 
presence of Tc grew at a slower rate (have high doubling times, and lower specific growth rates), 
compared to the four strains grown in the absence of Tc.  
 
 
 
 
3.3.5 Nitrogen limited growth assay of MSMEG_2196-pMind antisense/sense 
Growth experiments were conducted in triplicate with M. smegmatis WT, 
Ms/pMind, Ms/p2196 S and Ms/p2196 AS grown in HdeB N¯ limited media 
containing 0 ng/mL and 40 ng/mL of Tc.  The concentration of nitrogen in the HdeB 
media was reduced from 100 mM to 0.01 mM, and the standard errors were produced 
as described in 3.3.1.  OD600 absorbance readings were taken every 90 mins for the 
first 10 hrs then every 3 hrs daily for 2 days.  The growth curves of all four cultures 
are shown in figure 3.3.5.  The specific growth rates and doubling times were also 
calculated, and they are displayed in table 3.3.5.   
 
 
 
 
M. smegmatis 
strain 
Tc Log-phase specific growth 
rate (min-1) 
Doubling time 
(mins) 
M. smeg WT  - 0.002462 (± 0.00023670) 281 (± 30.48) 
M. smeg WT + 0.001471 (± 0.00021034) 471 (± 67.38) 
Ms/pMind  - 0.002542 (± 0.00043487) 273 (± 46.67) 
Ms/pMind  + 0.001662 (± 0.00024326) 417 (± 61.03) 
Ms/p2196 S - 0.002447 (± 0.00006200) 283 (± 7.17) 
Ms/p2196 S + 0.001713 (± 0.00011656) 405 (± 47.55) 
Ms/p2196 AS - 0.002409 (± 0.00001382) 288 (± 1.65) 
Ms/p2196 AS + 0.001639 (± 0.00014222) 423 (± 36.72) 
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From the growth curves and the calculated doubling times, it is clear that M. 
smegmatis WT (in the absence and presence of Tc) grew at a much faster rate at both 
exponential- and stationary-phase (low doubling times), compared to Ms/pMind.  
This observation is supported by the final OD600 readings, where M. smegmatis WT 
reached a final OD600 (at 3,390 mins) of 1.18 (Tc+), and 1.09    (Tc-), compared to 
Ms/pMind final OD600 of 0.54 (Tc+), and 0.67 (Tc-).  Ms/pMind and Ms/p2196 S 
culture, in both the presence and absence of Tc, had no significant effect (outside of 
standard errors there is no significant difference) on growth rate, which is clearly 
shown in the specific growth rates and doubling times calculated (Figure 3.3.5 and 
Table 3.3.5).   
Ms/p2196 AS culture, grown in the presence of Tc, had the most marked 
decrease in OD600 readings under both 0 ng/mL and 40 ng/mL of Tc up until ~1500 
mins (OD600 of 0.62 [Tc-], and 0.51 [Tc+]), compared to Ms/pMind (OD600 of 0.97 
[Tc-], and 1.12 [Tc+]).  After 2,000 mins, Ms/p2196 AS culture grown in the absence 
of Tc recovered their growth rate and seemed to have reached similar OD600 to that of 
Ms/pMind and Ms/p2196 S.  However in the presence of 40 ng/mL of Tc, the OD600 
of Ms/p2196 AS began to decrease just before 2,000 mins and kept decreasing 
steadily (540 mins of doubling time compared to 323 mins of doubling time for 
Ms/pMind at log-phase). Overall, the growth of Ms/p2196 AS culture was hindered 
under N¯ limitations in the presence of Tc, compared to the other three cultures.  This 
growth curve was repeated twice (data not shown) and equivalent results were 
obtained.     
  
 
 
(A) 
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(B) 
 
Figure 3.3.5:  Growth curve of M. smegmatis WT, Ms/pMind, Ms/p2196 S, and Ms/p2196 AS 
grown in HdeB N¯ limited media.  Growth of the four strains grown in HdeB N¯ limited media 
containing either 0 ng/mL (A), or 40 ng/mL (B) of Tc.  On the first day, the OD600 readings of the 
assays were taken every 90 mins, then every 3 hrs for 2 days.  The growth of Ms/p2196 AS culture 
grown in the presence of Tc (B) was affected significantly compared to Ms/p2196 AS in the absence of 
Tc (A).  The results were plotted on a semi-log graph, and the standard errors were calculated by 
dividing the standard deviation by the square root of 3 . 
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Table 3.3.5:  Specific growth rates and doubling times for N¯ limited growth assay in HdeB 
media.   Growth rates and doubling times of the four cultures grown in the HdeB N¯   limited media in 
the presence/absence of Tc.  There is a significant difference (outside of the standard errors) in the 
doubling time of Ms/p2196 AS culture compared to the other three cultures.  This demonstrates a 
growth effect in the Ms/p2196 AS grown under N¯ limitation due to the down-regulation of 
MSMEG_2196 in M. smegmatis.  
 
 
 
3.3.6 CFU of Ms/pMind and Ms/p2196 AS in N¯ limited culture 
CFU, a measurement of viable bacterial cells, were preformed on Ms/pMind 
and Ms/p2196 AS cultures grown in HdeB N¯ limited media (both 0 ng/mL and 
40ng/mL of Tc culture).  1 mL of cells at stationary-phase (1,440 mins and 2,880 
mins) was collected for CFU analysis (see section 2.4.2), and the results of the CFU 
values are shown in table 3.3.6.  At 1,440 mins, Ms/pMind CFUs (Tc- and Tc+) were 
greater than that of Ms/p2196 AS (Tc- and Tc+). At 2,880 mins, the CFU values of 
Ms/p2196 AS culture grown in the absence of Tc reached similar CFU values to that 
of Ms/pMind grown in both absence and presence of Tc.  However, the CFUs of 
Ms/p2196 AS culture grown in the presence of 40 ng/mL Tc decreased further.  The 
M. smegmatis 
strain 
Tc Log-phase specific growth 
rate (min-1) 
Doubling time 
(mins) 
M. smeg WT  - 0.002767 (± 0.0004680) 250 (± 42.30) 
M. smeg WT  + 0.002739 (± 0.0004047) 253 (± 37.37) 
Ms/pMind  - 0.001851 (± 0.0002728) 374 (± 55.08) 
Ms/pMind  + 0.002145 (± 0.0001486) 323 (± 22.38) 
Ms/p2196 S - 0.002196 (± 0.0003802) 316 (± 54.67) 
Ms/p2196 S + 0.002253 (± 0.0001309) 308 (± 17.90) 
Ms/p2196 AS - 0.001787 (± 0.0001514) 388 (± 32.88) 
Ms/p2196 AS + 0.001281 (± 0.0001833) 540 (± 77.25) 
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CFU values of both time points (1,440 and 2,880 mins) concur with the growth curve 
results shown in figure 3.3.5.  
 
 
 
(A) 
M. smegmatis 
strain 
Tc Cell concentration  
(CFU/mL) 
Percentage  
Ms/pMind  - 1.823 x 108 (± 85.82)  100.0% 
Ms/pMind + 1.176 x 108 (± 8.09) 64.5% 
Ms/p2196 AS - 8.33 x 107 (± 8.65) 45.7% 
Ms/p2196 AS + 8.05 x 107 (± 1.50) 44.2% 
 
(B) 
M. smegmatis 
strain 
Tc Cell concentration    
(CFU/mL) 
Percentage  
Ms/pMind  - 2.48 x 108 (± 25.77) 100.0% 
Ms/pMind  + 2.19 x 108 (± 11.00) 88.3% 
Ms/p2196 AS - 1.95 x 108 (± 19.73) 78.6% 
Ms/p2196 AS + 8.76 x 107 (± 1.45) 35.3% 
 
Table 3.3.6:  CFU counts of Ms/pMind and Ms/p2196 AS grown in N¯ limited culture. 
The CFU and percentage of Ms/pMind and Ms/p2196 AS culture grown in the N¯ limited media.  The 
cultures were collected for CFU at 1,440 mins (A), and then again at 2,880 mins (B). 
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3.4 Proteomics of Ms/pMind and Ms/p2196 AS  
 
3.4.1 Whole-cell protein extraction from Ms/pMind and Ms/p2196 AS culture 
for proteomic analysis 
The protein expression in Ms/p2196 AS culture grown under nitrogen 
limitation was analysed. Cells of all four cultures were harvested at stationary phase 
and stored at -80 °C.  Since there were a significant differences (outside of standard 
errors) observed in Ms/p2196 AS Tc+ culture (in term of the OD600 absorbance 
readings and CFU values), these and Ms/pMind Tc+ (used as control) cell culture 
were lysed using Triton X-100 and urea (see section 2.5.1).  Protein quantitation was 
performed using the Pierce kit, and samples were run on SDS-PAGE gel to check for 
the quantity of the protein present in the whole cell lysates (Figure 3.4.1).  The 
Triton-urea treated cell lysates of Ms/pMind and Ms/p2196 AS cultures grown under 
nitrogen-limited condition were selected for the 2D gel analysis.  
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Figure 3.4.1:  SDS-PAGE of whole cell lysates of Ms/pMind and Ms/p2196 AS cultures grown in 
nitrogen limited conditions.  Ms/pMind and Ms/p2196 AS cell culture grown in N¯ limited media, in 
the presence and absences of Tc were harvested at stationary phase (at time 1,800 mins) and were 
prepared for cell lysis.  Lane 1, control (MSMEG_2196/E.coli). Lanes 2 and 3, Ms/pMind Tc+ Triton 
X-100 treated (20 µL and 5 µL, respectively). Lanes 4 and 5, Ms/p2196 AS Tc+ Triton X-100 treated 
(20 µL and 5 µL, respectively). Lanes 6 and 7, Ms/pMind Tc+ Triton-urea treated (20 µL and 5 µL, 
respectively). Lanes 8 and 9, Ms/p2196 AS Tc+ Triton-urea treated (20 µL and 5 µL, respectively).  
Lanes 10 and 11, Ms/pMind Tc+ concentrated 5-fold (20 µL and 5 µL, respectively).  Lanes 12 and 13, 
Ms/p2196 AS Tc+ concentrated 5-fold (20 µL and 5 µL, respectively).  The Triton/urea treated 
Ms/pMind and Ms/p2196 AS (in lanes 6 and 8) were used for 2-D gel electrophoresis. 
 
 
 
 
 
3.4.2 Analysis of differentially expressed proteins in Ms/pMind and Ms/p2196 
AS strain grown in nitrogen-limited media 
The prepared protein samples of Ms/pMind (control) and Ms/p2196 AS 
culture grown in nitrogen limited media to stationary-phase were analysed by 2D gel 
electrophoresis.  Two pI ranges, 4-7 and 6-11, were used and analysed (see section 
2.5.2 – 2.5.4).  The results obtained are shown in figure 3.4.2 and 3.4.3.   
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The protein samples were analysed by 2D gel electrophoresis twice.  17 
protein spots from pI 4-7 2D gels (7 from Ms/pMind and 10 from Ms/p2196 AS), and 
31 protein spots from pI 6-11 2D gels (7 from Ms/pMind and 24 from Ms/p2196 AS), 
were selected.  The selection of the spots was determined using ImageMaster 2D 
Platinum 5.0 software (GE Healthcare/Amersham Biosciences).  We were not 
specifically searching for particular proteins, hence the selection was based on protein 
spots being absent and/or present, up regulated and/or down regulated in either gel.  
To quantify the change in protein expression, the selected spot intensities were 
quantified using ImageJ software.  In cases where the spot appeared and/or 
disappeared on either gel, baseline measurements were still detectable even though 
spots were not visible by eye. In these cases, the protein expression ratio calculated 
was high (between 20 and 30).  Spots of interest were trypsin digested and the 
resulting peptides analysed by MALDI-ToF-MS. 
  
 
   
 
 
 
 
 
 
 
 
 
 
Chapter 3: Results 
 70
 
 
 
Figure 3.4.2:  pH 4-7 2D gel electrophoresis of Ms/pMind (A) and Ms/p2196 AS (B).   
Colloidal coomassie-stained 2D gel of total protein isolated from stationary phase of M. smegmatis containing 
Ms/pMind (A) used as control and Ms/p2196 AS (B) grown in nitrogen limited media.  The protein spots on 
the two gels were compared using ImageMaster 2D platinum 5.0 software (GE Healthcare/Amersham 
Biosciences, New Zealand).  The red-circled spots were selected by the software as being expressed in one 
gel but not the other.  The black circles represent the proteins indicated by red circles in the opposite gel.  
There were some prominent spots that were present in both gels, such as spots A, D, E, F, G, and H; these 
were detected by ImageMaster software as being “not-identical”, however when observing these spots by eye, 
they seem to be identical spots.   
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Figure 3.4.3:  pH 6-11 2D gel electrophoresis of Ms/pMind (A) and Ms/p2196 AS (B).   
Colloidal coomassie-stained 2D gel of total protein isolated from stationary phase of M. smegmatis containing 
Ms/pMind (A) used as control and Ms/p2196 AS (B) grown in nitrogen-limited media.  The protein spots on 
the two gels were compared and selected using ImageMaster 2D platinum 5.0 software (GE 
Healthcare/Amersham Biosciences, New Zealand).  The red-circled spots were identified by the software as 
being present in one gel but not the other.  The black circles represent the red circles in the opposite gel.  
Black arrows represent spots selected by ImageMaster in both gels as being different however when 
identified, the proteins were identical.  The yellow circles are spots not detected by the ImageMaster software 
however when comparing the two gels by eye, they are detected in one gel but not the other.  These latter 
spots were not analysed.  
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3.4.3 Proteins identified on 2D gel 
For protein identifications of Ms/pMind and Ms/p2196 AS, the resulting mass 
spectra were analysed using the Mascot search engine database, from Science Matrix 
website (see section 2.5.5).  The identified proteins are listed in table 3.4.1.  Protein 
identification was significant (measure of the statistical significance of a match) if the 
protein scores were higher than 66 [88].  This is called the “score distribution” which 
is given by a histogram in the Mascot search result page.  If a search is included in the 
green shaded area then there is greater than a 5 % probability that the identification 
was random, conversely if search is outside the green shaded area than the matched 
protein had less than a 5 % probability of being a random event [88].  The molecular 
weight, pI values, and expectation values were other parameters looked at to check 
that proteins were not random matches.  The expectation value is the “number of time 
we would expect to obtain an equal or higher score, purely by chance” [88], the lower 
the expectation value the more significant the result is.  Most of the proteins 
identified in this study had a low expect value, which is encouraging.  Furthermore, 
molecular weight and pI values of each identified protein matches the spot being 
analyzed on the 2D gels, which add further confidence to the predicted protein match.  
Figure 3.4.4 gives an example of a Mascot search results.  The database search 
identified 41 % (pH 4-7 2D gels) and 46 % (pH 6-11 2D gels) of proteins searched 
for belonging to M. smegmatis mc2155 strain.  Not all of the proteins selected by 
MasterImage were identified.  This could be due to the M. smegmatis genome not 
being completely annotated at the time when this study was conducted.    
 
 
 
Chapter 3: Results 
 73
 
Figure 3.4.4:  Mascot search result of an identified protein.  An example of Mascot search result 
obtained when identifying a protein. The top section of the result page is the probability based Mowse 
score.  In this page the histogram probability of proteins identified (in the above example these are the 
red bar graph, outside the green shaded area) are significant.  The protein summary report, below the 
histogram, gives further details about the identified protein such as the mass of the protein (red circle), 
score number (black circle), and the expect value (red circle).  It also gives the name of the species for 
the identified protein, in this case M. smegmatis strain mc2 155 (red arrow).  To obtain more 
information on the identified protein, clicking on the accession number (red rectangle) will open a new 
window called “protein view” (bottom).  In this window, the pI value of the identified protein can be 
checked against the protein spot localisation on the 2D gel, and matched peptides are given in this 
page.  
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Table 3.4.1:  Proteins identified from 2D gel of Ms/pMind and Ms/p2196 AS 
 
Functiona                       Identity/homologyb                  Spot labels                Expression in                 pI                  Molecular mass         E-valuee                 Protein                   
                                                                                          from Figs 3.4.2          Ms/p2196 ASd                                                               (Da)                                                                       score 
                                                                                          and 3.4.3c                             (fold) 
RNA synthesis                DNA-directed RNA                     D                              + (1.40)                           4.62                   37954                        4.4e-05                      97         
and DNA synthesis         polymerase α-subunit.    
Adaptations and            Cold-shock binding                      24                            - (1.50)                             6.86                   16623                       0.00024                     90 
atypical condition          domain protein. 
Repressors/                    Transcriptional regulator            13                            - (1.20)                            9.57                    24760                       1.1e-11                     163 
activators                       Crp/Fnr family protein. 
 
                                         Nitrogen regulatory                     O                             - (13.90)                          5.82                   12108                        0.36                           65 
                                         protein P-II.    
Ribosomal protein         Ribosomal protein S7                   2                              + (13.30)                         10.5                   17618                       1.3e-09                     142  
synthesis and                  50S ribosomal protein L6             7                             + (31.40)                          9.99                  19442                       4.2e-07                     117 
modification                   Ribosomal protein L14                20/21                        - (32.00)                          0.06                  13425                       1.3e-06                     112 
                                         Ribosomal protein L10                14                            + (1.15)                            9.00                  18000                       5 .3e-09                    136  
                                         Ribosomal protein L1                  6                              + (1.70)                            9.60                  25004                       1.7e-10                     151 
                                         Ribosomal protein S10                23                            + (5.80)                            9.41                  11483                       3.3e-05                      98 
                                         Ribosomal protein L11                5                              + (52.4)                            9.52                  15050                       0.00520                     76 
Protein translation        Translation elongation                 C                             + (4.20)                            5.18                  43709                       0.00450                      77 
and modification            factor Tu. 
 
                                         Peptidyl-prolyl cis-trans              N                               =                                     5.42                   18714                      4.2e-07                     117 
                                         isomerase B. 
Chaperons                      Chaperon protein DnaK              A                              + (1.80)                            4.71                  66606                       2.1e-15                    200 
heat shock 
Biosynthesis of               Geranylgeranyl reductase           10                             + (28.00)                          9.30                   43182                       0.00033                     88 
Cofactor 
Ribosome                        Dimethyladenosine                      30                              + (1.40)                           7.12                   32813                       0.013                         72 
modification                   transferase   
and maturation 
Amino acid                     Glutamine synthetase                  K                              - (11.30)                           4.97                   53729                      4.2e-06                     107 
biosynthesis                     type I. 
 
                                         Glutamate 5-kinase.                     27                             - (11.30)                           6.77                  38583                       0.0046                       77 
Energy metabolism        Malate: quinine- 
                                         oxidoreductase                             28                              =                                      7.11                   54993                      1.2e-06                      52 
Others                             TROVE domain protein              18                              + (4.40)                           9.29                   61373                      1.1e-13                    183                   
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Table 3.4.1: Proteins identified from 2D gel of Ms/pMind and Ms/p2196 AS. 
All of the protein spots from the 2D gel (Fig 3.4.2 and 3.4.3) that were identifiable using the Mascot 
search engine (Science matrix database).  An explanatory footnote is given below for the headings 
presented inside table 3.4.1.  
 
a Functional categories given by the Mascot search database from Science matrix. 
b Functions as described in “The Institute of Genomic Research (TIGR) database for fully identified 
gene products or proposed function and/or homology for the others. 
c Spot labels:  letters according to those in Fig. 3.4.2; numbers according to those in Fig. 3.4.3. 
d Level of expression for each spot determined using ImageJ. 
“+”, up-regulated proteins; “-“, down-regulated proteins; “=”, proteins whom expression level was 
unchanged (in this case a protein spot having a ratio of 1 or less was labelled as having an equal 
amount of expression level in either the Ms/pMind or Ms/p2196 AS).  The ratio rates are indicated in 
brackets. 
e E-value is the number of times we would expect to obtain an equal or higher score, purely by chance.  
 The lower the E-value is the significant the results are.        
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3.5 Site directed mutagenesis of Mb1389c and MSMEG_2196 
 
3.5.1 PCR of Mb1389c and MSMEG_2196 flanking  regions 
To delete the Mb1389c (M. bovis) and MSMEG_2196 (M. smegmatis) genes, 
overlap PCR was used, where the flanking regions of the gene in question are amplified 
first. Since identical work was carried out on both M. bovis and M. smegmatis, in term of 
constructing the mutants, both were included in the same sections (see Materials and 
Methods sections 2.6.1-2.6.10).  The flanking regions (~ 600 bp) were amplified using 
the primers listed in table 2.6.1, and PCR products were run on 1 % agarose gel (Figure 
3.5.1 and 3.5.2) and gel purified. 
 
 
  
Figure 3.5.1: 1 % agarose gel of Mb1389c flanking region PCR.  Mb1389c upstream flanking region 
was amplified using Mb1389c C1/R4 primers (lane 3, ~650 bp), and downstream flanking region was 
amplified using Mb1389c F2/D2 primers (lane 4, ~650 bp).  Lane 2 contains negative control; lane 1 
contains 1Kb+ marker (Invitrogen, New Zealand). 
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Figure 3.5.2:  1 % agarose gel of MSMEG_2196 flanking region PCR.  MSMEG_2196 upstream flanking 
region was amplified using Ms_2196 C11/R11 primers, lane 2 (~ 650bp, 10µL/25µL), and the downstream flanking 
region was amplified using Ms_2196 F13/R16 primers, lane 3 (~ 650bp, 10µL/25µL).  Lane 4 contains positive 
control, and lane 5 contains negative control.  Lane 1 contains 1Kb+ marker (Invitrogen, New Zealand). 
 
 
 
3.5.2 Overlap PCR of Mb1389c and MSMEG_2196 
Overlap PCR was used to join the upstream-amplified flanking region of 
Mb1389c C1/F4 to the downstream flanking region of Mb1389c F2/D2 using methods 
previously described [56].  Initially, this protocol was also applied to join the upstream 
flanking region of Ms_2196 C11/R11 to the downstream flanking region Ms_2196 
F13/R16 with no success hence a second protocol was used [23] (see section 2.6.3).  This 
protocol was successful, and it gave the desired 1,200 bp product.  The PCR products 
were run on 1 % agarose gel and gel purified (Figure 3.5.3 and 3.5.4).  
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Figure 3.5.3:  1 % agarose gel of Mb1389c overlap PCR.  Mb1389c overlap PCR product was amplified 
using Mb1389c C1/D2 primers, lane 4 (~ 1.2 kbp).  Lane 2 contains negative control; lane 3 contains 
positive control.  Lane 1 contains 1 Kb+ marker (Invitrogen, New Zealand).  
 
 
 
  
Figure 3.5.4:  1 % agarose gel of MSMEG_2196 overlap PCR.  Overlap fragment of MSMEG_2196 
was amplified using Ms_2196 F11/R16 primers, lane 2 (~1.2kbp, 10µL/30µL).  Lane 3 contains positive 
control, and lane 4 contains negative control.  Lane 1 contains 1Kb+ marker (Invitrogen, New Zealand). 
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3.5.3 Cloning of Mb1389c- and MSMEG_2196-overlap fragment into pGEM-T 
Easy cloning vector 
pGEM-T Easy cloning vector was used, into which the Mb1389c and 
MSMEG_2196 overlap PCR fragments were ligated.  The resulting p1389c-overlap 
recombinant plasmids were digested with EcoR I to check for the correct Mb1389c insert 
(~1.2kbp).  The resulting p2196-overlap recombinant plasmids were digested with Pac I 
enzyme to check for the correct MSMEG_2196 insert (~1.2kbp).  The digested reaction 
was run on a 1 % agarose gel (Figure 3.5.5 and 3.5.6).   
The plasmids that contained Mb1389c and MSMEG_2196 ~1.2kbp fragment 
were sequenced by Allan Wilson Centre (New Zealand).  The chromatograms of the 
sequences were corrected and examined for fidelity and absence of mutations (data not 
shown). 
 
 
 
Figure 3.5.5:  1 % agarose gel of p1389c-overlap EcoR I digested fragment.  Lanes 2-12 contains p1389c-
overlap digested with EcoR I enzyme (15µL/25µL).  Inserts of Mb1389c are present in lanes 2 and 10.  Lane 1 contains 
1Kb+ marker (Invitrogen, New Zealand). 
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Figure 3.5.6:  1 % agarose gel of p2196-overlap Pac I digested fragment.  p2196-overlap plasmids were 
digested with Pac I enzyme, lane 2-11.  MSMEG_2196 inserts present in lanes 3, 4, 6, 7, 8, 9, and 11.  
20µL/25µL per lane of Pac I digested reaction was run on gel.  Lanes 1 and 12 contains 1 Kb+ markers 
(Invitrogen, New Zealand). 
 
 
 
3.5.4 Digestion of Mb1389c- and MSMEG_2196-overlap fragment  with Pac I 
enzyme for ligation into pUHA778 vector 
To prepare the Mb1389c- and MSMEG_2196-overlap PCR fragments for ligation 
into the knock-out vector pUHA778, the purified overlap PCR products were first 
digested with Pac I enzyme. The digested products were run on a 1 % agarose gel, and 
they were gel purified (Figure 3.5.7, and 3.5.8). 
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Figure 3.5.7:  1 % agarose gel of Mb1389c-overlap Pac I digested fragment.  The expected ~ 1.2 kbp 
digested product of Mb1389c-overlap (lanes 2 and 3). These products were gel purified. 
 
 
 
      
Figure 3.5.8:  1 % agarose gel of MSMEG_2196-overlap Pac I digested fragment.    The expected 
digested product of MSMEG_2196-overlap is ~ 1.2 kbp in lane 2.  Lane 1 contains 1 Kb+ marker 
(Invitrogen, New Zealand)   
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3.5.5  Ligation of Mb1389c- and MSMEG_2196-pverlap Pac I digested fragments 
into pUHA778 plasmid 
The ligation of Mb1389c- and MSMEG_2196-overlap fragments into pUHA778 
plasmid generated pUHA778-Mb1389c and pUHA778-MSMEG_2196 fragments.  These 
fragments were transformed into E. cloi DH5α cells (Section 2.6.6), and the resulting 
recombinant plasmids were digested with Pac I enzyme and run on 1 % agarose gel 
(Figure 3.5.9 and 3.5.10), to check for the presence of insert. 
 
 
 
Figure 3.5.9:  1 % agarose gel of Mb1389c-pUHA778 recombinant plasmids Pac I digested.  Lane 1 
contians 1Kb+ marker (Invitrogen, Auckland, New Zealand).  Lanes 2-12 contains Mb1389c-pUHA778 
plasmids digested with Pac I enzyme.  Lane 8 contains Mb1389c insert.  
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Figure 3.5.10:  1 % agarose gel of MSMEG_2196-pUHA778 recombinant plasmids Pac I digested.  
Lanes 2-6 contains MSMEG_2196-pUHA778 plasmids.  Lane 2 contains the desired MSMEG_2196 insert. 
 
 
 
 
3.5.6 Generation of M. bovis-1389c mutants 
  Generation of M. bovis Mb1389c mutants was carried out at AgResearch Ltd. 
Wallaceville, New Zealand PC3 laboratory.  At AgResearch PC3 laboratories, the 
Mb1389c-pUHA778 fragment was transformed in M. bovis (Section 2.6.8). Since M. 
bovis is a slow growing bacterium the transformants’ incubation period took 3 weeks.  
The first resulting colonies of M. bovis Δ1389 were heat killed from which gDNA 
extraction was carried out and run on 1 % agarose gel (Figure 3.5.11).  To check for first 
cross-over and/or second cross-over PCR was carried out using primers shown in table 
2.6.4, different combinations of these primers was used.  Varying PCR conditions were 
applied such as gradient annealing temperature PCR, as well as normal PCR (Table 
2.3.1); however, unspecific amplifications resulted each time (data not shown).  Southern 
blot was carried out to screen for the first cross-over and/or knockouts of Δ1389 in M. 
bovis.  gDNA of the first heat killed colonies were digested with Bgl II enzyme and run 
on 0.8 % agarose gel (Figure 3.5.12) and then run on Southern blot (results not shown).   
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The fragment size of Bgl II in wild type M. bovis1389c is 13,818 bp.  Hence in first 
cross-over we are looking for a shift from the wild type 13,818 bp band to a larger band 
size that contains wild type fragment and the inserted DNA (this includes the 1,200 bp 
flanking regions plus 7,506 bp of pUHA778 plasmid) giving a total size of 22,524 bp 
figure 3.5.13.  In the second cross over pUHA778 plasmid should not be present, giving 
either Mb1389c wild type gene (the reversion of Mb1389c gene to wild type) or the 
mutated Mb1389c gene, figure 3.5.14.   
More heat killed colonies of M. bovis Δ1389 were treated as mentioned earlier for 
the Southern blot.  At this stage no first cross over and/or second cross over (knockout) of 
M. bovis Δ1389 were present in the samples obtained, it is possible that more colonies 
need to be screened for.  Table 3.5.1 summarises the construction of the Mb1389c 
mutation in M. bovis. 
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Figure 3.5.11:  1 % agarose gel of gDNA of M. bovis Δ1389 colonies.  Lanes 2-25 (top and bottom wells) 
contain gDNA of heat-killed M. bovis Δ1389 plasmids obtained from AgResearch.  Lane 1 of the top and 
bottom halves of the gel contains 1kb+ marker (Invitrogen, New Zealand). 
 
 
 
 
 
 Figure 3.5.12:  0.8 % agarose gel of M. bovis Δ1389 gDNA digested with Bgl II enzyme.  Bgl II 
enzyme was used to digest M. bovis Δ1389 gDNA for southern blot analysis.  Top wells, lanes 4-25 contain 
Bgl II digested samples, bottom wells contain the same samples however are not Bgl II digested.  Lane 2 
(top and bottom wells) contains wild type M. bovis gDNA, used as positive control.  Lane 3 (top and 
bottom wells) contains wild type M. smegmatis gDNA, used as negative control.  
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Figure 3.5.13:  The expected fragment size of first crossover of Mb1389c-pUHA778 in Southern blot.  
The expected sizes would be wild type M. bovis 1389c (~ 13,818 bp) plus pUHA778 plasmid (~ 7,506 bp) 
and the flanking region fragment (1,200 bp), giving a total fragment size of 22,524 bp.  Lines not drawn to 
scale. 
 
            
Figure 3.5.14:  The expected fragment size of second crossover of Mb1389c-pUHA778 in Southern 
blot.  The possible fragments will be either the reversion of Mb1389c to wild type which will produce a 
fragment size of 13,184 bp (A).  Alternatively, it will give the size of the mutated gene of Mb1389c, which 
will be 11,942 bp.  Lines not drawn to scale. 
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3.5.7 Generation of M. smegmatis-2196 mutants 
The MSMEG_2196-pUHA778 plasmids, with the right insert, were transformed 
into M. smegmatis and plated out onto LA Hyg50 agar plates.  The transformation was 
carried out using a Bio-Rad E. coli pulser, where kV was the only variable, and the 
electroporator did not contain micro Faraday (mF) and Ohms (Ω) variable functions.  The 
resulting colonies were inoculated into 3 mL of LB broth containing Hyg50 and 0.1 % 
Tween 80, to make stock culture and to extract gDNA. 
Initially PCR was carried out to check for the presence of single homologues 
recombination and/or knockout of MSMEG_2196 in M. smegmatis.  Primers used are 
shown in table 2.6.5, and combination of these primers was employed for PCR.  The PCR 
amplification gave either a product similar to that of MSMEG_2196 wild type and/or 
unspecific amplifications, even though the positive control gave the correct fragment size 
(data not shown).  Southern blot was applied; gDNA samples of M. smegmatis Δ2196 
were digested with EcoN I enzyme and run on 0.8 % agarose gel (Figure 3.5.15).   
EcoN I enzyme cuts twice outside the MSMEG_2196 gene and it does not have 
digestion sites inside the pUHA778 plasmid.  Hence, fragments of the first crossover 
and/or second cross-over should be readily obtained.  EcoN I gives a fragment size of 
5,398 bp in the wild type MSMEG_2196; in the first crossover, we are expecting a shift 
from the wild type to a larger fragment of 14,054 bp (Figure 3.5.16).  In the second 
crossover (gene knock out), the pUHA778 plasmid will be lost giving a fragment of 
either 5,398 bp (reversion to wild type) or a smaller fragment consisting of 3,303 bp 
(Figure 3.5.17). The EcoN I digested MSMEG_2196-pUHA778 gDNA were run on 
Southern blot (data not shown).  The knockout fragment of MSMEG_2196 was not 
present in the Southern blot analysis; neither was in PCR reaction. More colonies need to 
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be screened on Southern blot.  Table 3.5.1 summarises the construction of the 
MSMEG_2196 mutant in M. smegmatis. 
 
 
 
  
Figure 3.5.15:  0.8 % agarose gel of gDNA of M. smegmatis Δ2196 digested with EcoN I enzyme.  The 
few resulting MSMEG_2196-pUHA778 colonies from the transformation were selected and gDNA was 
extracted.  gDNA was digested by EcoN I.   Lanes 5-23 (top wells) and lanes 2-23 (bottom wells) contain 
MSMEG_2196-pUHA778 EcoN I digests.  Lanes 2, 3, and 4 (top wells) contains undigested M. bovis wild 
type; undigested M. smegmatis wild type, and Econ I digested M. smegmatis wild type gDNA, respectively.  
Lanes 1 and 24 (top and bottom wells) contains 1kb+ marker (Invitrogen, New Zealand). 
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Figure 3.5.16:  The expected first cross-over fragment sizes of MSMEG_2196-pUHA778 in Southern 
blot.  Wild type MSMEG_2196 cut with Econ I enzyme will give a fragment size of 5,398 bp.  In the first 
cross over we expected to see a shift from the wild type to 14,054 bp fragment (this is the total size of wild 
type MSMEG_2196, the pUHA778 plasmid, MSMEG_2196 overlap fragment [~ 1200 bp], and some of 
the M. smegmatis chromosome as shown in the above figure.  Lines not drawn to scale. 
 
 
 
Figure 3.5.17:  The expected fragment sizes of second crossover of MSMEG_2196-pUHA778 in 
Southern blot analysis.  In the second cross-over the pUHA778 plasmid is lost resulting with two 
fragments in the Southern blot; either a fragment of 5,398 bp (reversion to wild type) as shown in the above 
figure (A), or the mutants MSMEG_2196 fragment of 3,303 bp, as shown in the above figure (B).  Lines 
not drawn to scale. 
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Experimental procedures Mb1389c (M. bovis) MSMEG_2196 
 (M. smegmatis) 
Upstream flanking region Completed  Completed  
Downstream flanking region Completed  Completed  
Overlap deletion fragment Completed  Completed  
Overlap insertion into pUHA778 Completed  Completed  
M. bovis/M. smegmatis mutants Unfinished Unfinished  
 
Table 3.5.1:  Summary of Mb1389c and MSMEG_2196 mutant construction work in M. bovis and M. 
smegmatis, respectively.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4:  Discussion and future directions 
 91
 
4. Discussion 
This study looked at the possible role of a cyclic nucleotide, c-di-GMP, in M. 
tuberculosis using M. smegmatis as the model strain.   The M. tuberculosis genome 
contain 1 gene, annotated as Rv1354c that codes for a GGDEF and EAL domain 
containing protein.  In other bacteria proteins containing GGDEF and EAL domains are 
known to synthesise and degrade c-di-GMP, respectively [68, 72, 75, 82,101, 122, 136, 
and 137].  No previous work has been carried out on c-di-GMP in mycobacteria.  c-di-
GMP is ubiquitous in bacteria [25, 26, and 82] (Reviewed in [32], [41], [62] and [109]) 
and many biosynthesis pathways use c-di-GMP to control responses such as biofilm 
formation, motility, sessility, and virulence behaviour [36, 37, 42, 44, 49, 53, 54, 55, 68, 
74, 76, 77, and 81] (Reviwed in [62]). 
 This study investigated the growth effect and protein expression that the Rv1354c 
orthologue (MSMEG_2196) had on M. smegmatis due to the changes made in its 
expression level under different growth conditions.  MSMEG_2196 antisense expressing 
strain grown in nitrogen-limited condition had a growth defect.  The OD600 values at mid- 
stationary-phase (30 hrs) of MSMEG_2196 were 0.60 compared to OD600 values of 1.09 
for M. smegmatis/pMind (control).  Colony forming unit (CFU) measurements further 
confirmed the growth effect seen in the OD600 of MSMEG_2196 antisense expressing 
strain. Proteomic analysis of the Ms/p2196 antisense strain demonstrated a difference in 
protein expression compared to Ms/pMind (control).  The construction of Rv1354c 
mutants in M. bovis (Mb1389c) and M. smegmatis was also initiated.  
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4.1 The effect of modification of MSMEG_2196 expression in M. 
smegmatis 
Antisense and sense fragments of MSMEG_2196 were constructed using the pMind 
expression vector. The plasmids were transformed into M. smegmatis, this produced M. 
smegmatis strains containing an altered expression of MSMEG_2196: a sense-expressing 
strain (Ms/p2196 S) and an antisense-expressing strain (Ms/p2196 AS).   
To test and observe the effect that expression of MSMEG_2196 sense and antisense 
had on the growth of M. smegmatis at exponential-phase and stationary-phase, growth 
curves were conducted using nutrient-rich (LB broth) and nutrient-limited (Hartman de-
Bonts) media.  All of the growth assay experiments were performed in triplicate in the 
presence or absence of tetracycline.  Two controls were used; M. smegmatis wild type, 
and M. smegmatis/pMind, and the two experimental strains examined were Ms/p2196 
sense and Ms/p2196 antisense expressing strains.   
The growth of all four strains, M. smegmatis WT, Ms/pMind, Ms/p2196 S, and 
Ms/p2196 AS, in LB broth rich media (in the presence and absence of tetracycline) was 
not affected.  There was no significant difference, outside of standard errors, in specific 
growth rates and doubling times of the Ms/p2196 S and Ms/p2196 AS strains. There were 
no significant growth effects (outside of standard errors), observed in the four strains 
grown either in the carbon, oxygen, or phosphorous nutrient limited HdeB media.  A 
significant growth effect (outside of standard errors) was observed in the Ms/p2196 
antisense expressing strain in the nitrogen-limited growth assay.  
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The Ms/p2196 antisense strain had the most pronounced decrease in OD600 values 
compared to M. smegmatis WT, Ms/pMind or Ms/p2196 sense.  The CFU at 24 and 48 
hrs were measured (Table 3.3.6), and the decreased growth of Ms/p2196 antisense strain 
in the nitrogen-limited media was confirmed by the lower CFU counts.  Final OD600 
values of all four strains grown in the nitrogen limited condition are displayed in graph 
4.1.1. There was a 42 % decrease in the final OD600 readings of Ms/p2196 antisense 
expressing strain in the presence of tetracycline compared to that of 52 % drop in the 
Ms/pMind (control).  This implies that the down-regulation of MSMEG_2196 in M. 
smegmatis had a significant effect on the cell growth.  
 
 
          
Graph 4.1.1:  Final OD600 reading of N¯ limited growth assay.  The final OD600 readings of the three 
strains: Ms/pMind, Ms/p2196 sense, and Ms/p2196 antisense grown in the presence/absence of Tc.  In the 
presence of Tc Ms/p2196 antisense expressing strain was the most affected compared to the control 
Ms/pMind, or the Ms/p2196 sense expressing strain.  The results represent the mean plus standard error of 
the final OD600 of the three triplicates for each culture in the presence/absence of Tc. 
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4.2 Proteins identified in Ms/p2196 antisense strain grown in the 
nitrogen limited-media 
To examine the effect Ms/p2196 antisense expression strain had on protein 
expression in M. smegmatis, the Ms/p2196 antisense (Tc +) and Ms/pMind (Tc+) control 
cultures were grown in 20 flasks (10 flasks for each strain) containing 50 mL of HdeB 
nitrogen-limited media and were harvested at stationary phase (at 1,800 mins).  Whole 
cell protein extraction was carried out on these cultures and were analysed by 2D gel 
electrophoresis.   
 Two proteins that were down-regulated in Ms/p2196 antisense were nitrogen 
regulatory protein PII (spot O), down-regulated 13.9 fold, and glutamine synthetase type I 
(spot K), down-regulated 11.3 fold (Table 4.2.1).  Both differentially expressed proteins 
have possible roles in nitrogen metabolism [63, 85, 98, 99, 104, and 105] (Reviewed in 
[79]).  In M. smegmatis, nitrogen regulatory protein PII is annotated as MSMEG_2426 
(no gene name has been given in TIGRFAM database) and the M. tuberculosis 
orthologue is Rv2919 (glnB) (Table 4.2.1).  M. smegmatis has two genes that are 
annotated as glutamine synthetase type I; MSMEG_4290 and MSMEG_4294 (both genes 
are annotated in TIGRFAM databse as glnA), and their orthologues in M. tuberculosis are 
Rv2220 (glnA1) and Rv2222c (glnA2), respectively (Table 4.2.1).   
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Proteins identified in 
Ms/p2196 AS 
Orthologue in 
M. tuberculosis 
Amino acid 
Identities 
(%) 
E-value 
MSMEG_2426  
(Nitrogen regulatory protein PII) 
Rv2919 (glnB) 81 9.1e-44 
MSMEG_4290 (glnA) 
MSMEG_4294 (glnA) 
(Glutamine synthetase typeI) 
Rv2220 (glnA1) 
Rv2222c (glnA2) 
83 
83 
1.6e-221 
3.0e-205 
 
Table 4.2.1:  The down-regulated nitrogen regulatory proteins identified by 2D gel analysis of 
Ms/p2196 antisense expressing strain.  This table lists the genes that were down-regulated in the 2D gel 
analysis of Ms/p2196 antisense grown in nitrogen-limited media.  These proteins have a possible role in 
nitrogen metabolism.  
 
 
 
 
4.2.1 Nitrogen metabolism in bacteria, and its possible role in MSMEG_2196 in 
Ms/p2196 antisense strain 
Nitrogen is crucial for amino acid and nucleic acid biosynthesis [4].  Bacteria have 
evolved a number of ways to acquire nitrogen from sources such as ammonium, which 
can then be directly incorporated into glutamine and glutamate (Reviewed in [92]).  In 
most bacteria, nitrogen availability is sensed by the glutamine level inside the cell 
whereby, low intracellular glutamine level signals low nitrogen availability [63]. The 
synthesis of glutamine is controlled by glutamine synthetase (GS), which is encoded by 
glnA gene [64, 86], hence its key function in nitrogen metabolism [64, 86]. 
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The mechanism of nitrogen metabolism has been well documented in E. coli    [85, 
86, and 105] (Reviewed in [70] and [106]), where post-translational modification is 
known to be involved in controlling the GS activity during nitrogen assimilation [85, 
105].   GS post-translational modification is controlled by proteins such as PII (encoded 
by the gene glnB), and GlnD (an uridylyl transferase/uridylyl removing enzyme that 
senses the nitrogen state of cell, and changes PII protein) [63 and 104] (Reviewed in 
[107]).  The GlnB protein is involved in regulating the two-component system proteins 
NtrB/NtrC (involved in nitrogen metabolism) (Reviewed in [92]), as well as controlling 
the expression of genes involved in nitrogen assimilations such as GS [105] (Reviewed in 
[92], [93] and [128]).   
In the case where intracellular glutamine is reduced (hence low nitrogen), GlnD 
senses the nitrogen reduction causing uridylylation of the PII protein [60, 63, 120, and 
126], and the formation of the PII-UMP complex.  The PII-UMP complex can not bind to 
NtrB, which allows NtrB mediated NtrC phosphorylation (NtrC-P), leading to the 
activation of glnA gene translation [4, 61, 64, and 104], and an increase in GS production 
and glutamine synthesis (Figure 4.2.1).  
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Figure 4.2.1:  The mechanism of glutamine production in E. coli under nitrogen starvation.  PII in E. coli is 
the central regulator of nitrogen metabolism.  Signal transduction components and metabolic enzymes also play a 
major role as shown in this figure.  When extracellular nitrogen availability is limited (1a), or the intracellular 
glutamine concentration decreases (1b), GlnD senses this decrease (2), which then brings about the uridylylation 
of PII protein (3).  The uridylylated PII (PII-UMP) (4) can not bind to the two-component system NtrB protein (5), 
this NtrB protein can then phosphorylate NtrC (6) which activates the transcription of glnA gene (7) to increase 
the production of GS (8), and the synthesis of glutamine (9).  The two proteins that were down-regulated in the 2D 
gel analysis of Ms/p2196 antisense expressing strain are PII and GlnA (pink boxes).   
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It is possible that the down-regulation of MSMEG_2196 in M. smegmatis grown in 
nitrogen-limited condition could have hindered the production/synthesis of PII protein 
either directly or indirectly, hence its absence in 2D gel analysis of Ms/p2196 antisense 
culture in this study. This in turn could have interrupted the down-stream signalling 
pathways involved in glutamine synthetase production and glutamine synthesis (Figure 
4.2.2).  Although the cells might still be able to sense the depleted nitrogen and glutamine 
concentration inside and/or outside the cell the cells are not able to synthesise GS.  
Therefore, the cells will use up all the glutamine and/or ammonia that is available and 
will become starved for nitrogen.  This could explain the Ms/p2196 antisense culture 
growth behaviour in the presence of tetracycline, where OD600 values never reached an 
OD600 value similar to that of Ms/pMind control, and after a short while (after 30 hrs) the 
OD600 decreased further.  However, further experimental procedures, such as RT-PCR or 
Western blotting needs to be carried out to confirm the reduction of intracellular 
expression level of MSMEG_2196 in the Ms/p2196 antisense culture.   
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Figure 4.2.2:  Proposed c-di-GMP function in M. smegmatis.  A hypothetical functional role of c-di-GMP in 
nitrogen metabolism in M. smegmatis.  The decreased-expression of MSMEG_2196 (c-di-GMP), caused by 
Ms/p2196 antisense expressing strain, could have had an effect on the synthesis of PII protein either directly or 
indirectly.  This in turn would have disrupted the down-stream signalling pathway of GS synthesis.  The two 
proteins that were down-regulated in the 2D gel analysis of Ms/p2196 antisense expressing strain were PII and 
GlnA (pink boxes).  Dashed lines indicate roles of effectors, solid lines indicate modifications, and blunt lines 
indicate negative effect.    
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4.2.2 Other down-regulated proteins in Ms/p2196 antisense culture 
The other down-regulated proteins were glutamate 5-kinase, a member of the 
transcriptional regulator Crp/Fnr family protein, and two ‘cold-shock’ binding domain 
proteins. In M. tuberculosis, glutamate 5-kinase (proB), down-regulated 2.8 fold (spot 27, 
figure 3.4.1), is involved in amino acid biosynthesis [27] similar to glutamine synthetase 
glnA1 (Rv2220) gene.   
Glutamate 5-kinase (G5K) is an enzyme involved in the first step of the proline 
synthesis pathway [3] (Reviewed in [80]).  Proline is synthesised from glutamine, and 
intracellular proline accumulation exerts a negative feedback effect that causes inhibition 
of G5K activity [40 and 124] (Reviewed in [80]).  In bacteria, proline is used as a source 
of energy, a source of carbon, and nitrogen, and to protect against osmotic stress [40,124, 
and 127].  The increase in osmolarity, for example during stress, inside bacterial cells 
causes an increase in proline concentration that has been demonstrated to assist in 
bacterial growth [10, 30, 31, and 119].  In the present study, the absence of G5K (not 
present on the 2D gel of protein identified) in Ms/p2196 antisense expressing strain 
grown in nitrogen-limited condition could have occurred due to the decreased level of 
MSMEG_2196 (c-di-GMP) inside the cell, as it was present in the Ms/pMind control 
atrain.   
     Members of the transcriptional regulator Crp/Fnr family proteins (a component 
of cyclic AMP receptor protein [CRP] and fumurate nitrate reductase regulator [FNR] 
family protein) [1], are involved in mechanisms such as carbon, sulphur, nitrogen 
metabolism, nitrogen fixation, and expression of virulence genes [46, 73].  In E. coli, 
CRP proteins are shown to be involved in the expression of many genes and in turn; gene 
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 expression is controlled by the intracellular concentration of cAMP [43].  The M. 
smegmatis genome contains at least four transcriptional regulatory proteins,  
MSMEG_0539, MSMEG_6189 (Rv3676 in M. tuberculosis), and MSMEG_2600 
(Rv1710 in M. tuberculosis).  The down-regulation of the transcriptional regulator 
Crp/Fnr family protein in the Ms/p2196 antisense expressing strain could have, directly 
or indirectly, been affected by the down-regulations of MSMEG_2196.  This is possible 
because previous studies with M. tuberculosis have linked its function with second 
messenger cAMP [8]. 
A ‘cold-shock’ DNA binding domain protein (CSP), spot 24, was down-regulated 
1.5 fold in the Ms/p2196 antisense strain (Figure 3.4.1).  In bacteria, this protein is 
usually expressed when bacterial cells undergo a temperature transition, for example a 
decrease in temperature from 37 °C to 15 °C [102].  This decrease in temperature causes 
some bacteria, such as E.coli, to undergo a “growth arrest” [67], while other bacteria such 
as the gram-positive B. subtilis, continue to grow in cold temperatures, but at a very slow 
rate [144].  The expression of cold-shock proteins under decreased temperature helps the 
cells to cope with the stress by maintaining the cell’s transport, replication and energy 
production, and it helps to maintain proper protein folding, protein biosynthesis and 
primary metabolism [18, 39, 45, and 67] (reviewed in [33]).  
In addition, CSP are involved in other stress conditions.  For example, under 
osmotic and oxidative stress, CSP in E. coli are shown to regulate stress proteins such as 
OsmY, Dps, ProP and KatG [38].  CSP presence in Ms/pMind (control) grown in the 
nitrogen limited media under optimum temperature (37 °C) indicates its presence to be of 
importance for mycobacteria in stress conditions.  The down-regulation of a CSP in  
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Ms/p2196 antisense expressing strain could have been a direct or indirect result of down-
regulation of MSMEG_2196 in the cells.  
 
 
 
4.2.3 Up-regulated proteins in Ms/p2196 antisense culture 
The Chaperon protein DnaK, spot A (Table 3.4.1), was up-regulated 1.8 fold.  In 
M. smegmatis it is annotated as MSMEG_0709 and its function is predicted to be a 
chaperon protein DnaK. MSMEG_0709 orthologue in M. tuberculosis is Rv0350 its 
function in M. tuberculosis is assigned as “DnaK, 70KD heat-shock protein, and 
chromosome replication” [27].  The M. tuberculosis’ genome contains seven genes 
potentially coding for heat-shock proteins [27, 127].  Like cold shock proteins, the 
expression of heat-shock proteins (HSP) in bacteria occurs when the cells undergo a 
change in temperature and/or stress conditions [123] (Reviewed in [83]).  The main 
function of HSPs is to prevent the accumulation and misfolding of proteins, and allow 
protein refolding and correct protein assembly in both normal and stress conditions [21, 
29 and 35] (Reviewed in [52], [59] and 143).  It is possible that the up-regulation of 
chaperon protein DnaK and HSP proteins in the 2D gel analysis of Ms/p2196 antisense 
expressing strain could have been induced as the cells in the nitrogen-limited condition 
started to die off, or became stressed.   
There were a number of strongly up regulated proteins in Ms/p2196 antisense 
culture.  One of these proteins is geranylgeranyl reductase; spot 10, up regulated 28 fold 
(Table 3.4.1).  The M. smegmatis genome contains two geranylgeranyl reductase genes: 
MSMEG_1028 and MSMEG_2308.  In M. smegmatis, the two-geranylgeranyl reductases 
have a cellular functional role of cofactor biosynthesis; their molecular function is  
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assigned as FAD binding proteins [133].   A study conducted on expression of putative 
proteins in M. tuberculosis under stress condition showed Rv0561c (an orthologue of 
geranalygeranyl reductase) to be expressed as one of the possible “stress signalling 
molecule” [34].  It is hypothesised that Rv0561c, along with other stress signalling 
molecules, can act as a back-up stress signal to sigma factor SigF [34].  M. tuberculosis 
cells exposed to NaCl2 stress displayed a 12-fold up-regulation of Rv0561c [34]; 
exposure to methyl viologen (a super-oxide generator) also caused an up-regulation in the 
expression of Rv0561c [34].  No studies have been conducted with this gene in M. 
smegmatis.  The up-regulation of this geranylgeranyl reductase in Ms/p2196 antisense 
expressing strain could have been caused by the down-regulation of MSMEG_2196, 
directly or indirectly, or it could have been induced due to the cells becoming stressed in 
the nitrogen limited condition.   
Other strongly up-regulated proteins seen in Ms/p2196 antisense were 50S 
ribosomal protein L6 (rplF), spot 7, up-regulated 31.4 fold, ribosomal protein L14 (rplN), 
spot 20/21, up-regulated 32 fold, and ribosomal protein L11 (rplK), spot 5, up-regulated 
52.4 fold, (Table 3.4.1).  The main functional role of ribosomal proteins is protein 
synthesis; hence, their expression is crucial to maintain growth of bacterial cells.  
The up-regulation of these ribosomal proteins in Ms/p2196 antisense is very 
interesting as most studies conducted on protein expression of M. tuberculosis grown in 
starvation media, for example oxygen and carbon starvation, have shown that in most 
cases mycobacterial ribosomal proteins are mainly down-regulated [12, 13, and 58] 
(Reviewed in [92]).  The production of protein in bacterial cells require energy and it is 
consistent that cells undergoing starvation discontinue protein synthesis [13, 58,  and 91]; 
also, mycobacterial cells in stationary phase do not carry out translation due to the 
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 possibility of introducing errors in transcription/translation [141] (Reviewed in [140]).  
Other ribosomal proteins that were slightly up-regulated were ribosomal protein S7, spot 
2, up-regulated 13.3 fold, ribosomal protein L10, spot 14, up-regulated 1.15 fold, 
ribosomal protein L1, spot, 6 up-regulated 1.7 fold, and ribosomal protein S10, spot 23, 
up-regulated 5.8 fold (Table 3.4.1).  It is possible that the up-regulation of all these 
ribosomal proteins are due to the down-regulation of MSMEG_2196, this could have 
been affected directly or indirectly in the nitrogen limited condition.  
The phenotypic effect in terms of the growth defect observed in the Ms/p2196 
antisense strain in nitrogen limited media appears to be specific for nitrogen starvation, as 
there was no phenotypic growth effect observed in the carbon-, phosphorous-, or oxygen- 
limited growth media.  2D gel electrophoresis analysis of Ms/p2196 antisense culture 
grown in nitrogen-limited media has allowed observation of the proteins expressed and/or 
down-regulated that could be playing role in c-di-GMP related signalling pathways in M. 
smegmatis.  
It is clear, from the results presented in this study, that Ms/p2196 antisense had a 
significant impact on M. smegmatis cell growth compared to Ms/pMind (control), and it 
is possible that c-di-GMP in mycobacteria could be acting in a similar manner as cAMP 
having second messenger characteristics that regulate various signalling pathways. 
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4.3 Model of the role of MSMEG_2196 in mycobacterial physiology 
and virulence behaviour 
The study of Ms/p2196 antisense expressing strain in the nitrogen limited condition 
has led to a phenotypic effect where cell growth was mostly affected under nitrogen 
starvation.  Further proteomic analysis of Ms/p2196 antisense expressing strain grown in 
the nitrogen limited condition has shown two down-regulated proteins that are known to  
be involved in nitrogen synthesis: nitrogen regulatory protein PII (glnB), and glutamine 
synthetase type I (glnA) [63, 85, 98, 99, 104, and 105] (Reviewed in [79]. 
Studies based on nitrogen synthesis in mycobacteria have shown nitrogen 
regulatory protein PII (GlnB) to be essential whereby the construction of glnB mutant was 
shown to be lethal [98, 99, and 104].  Study based on the GS gene glnA1 in M. 
tuberculosis is shown to be of importance for virulence [138], whereby glnA1 mutant was 
shown to be a “glutamine auxotroph” (is not able to synthesise glutamine) and had a 
decreased ability to divide in infected macrophages and guinea pigs [138].  Although M. 
tuberculosis genome encodes four glnA genes (glnA1-4), only glnA1 is shown to be 
involved in the action of glutamine synthetase [51, 138].  The reduced-expression of 
nitrogen regulatory protein PII (glnB) and glutamine synthetase type I (glnA) seen in the 
2D gel analysis of Ms/p2196 antisense expressing strain in nitrogen-limited condition 
could have been caused by the down-regulation of MSMEG_2196, either directly or 
indirectly.  This gives the possibility that MSMEG_2196 could be involved in the 
signalling pathways of nitrogen metabolism, which in turn is of importance in the 
virulence behaviour of mycobacteria.   
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The other protein seen to be down-regulated in Ms/p2196 antisense expressing 
strain was the transcriptional regulator Crp/Fnr proteins.  M. tuberculosis genome 
contains two transcriptional regulator Crp/Fnr genes: Rv1719 and Rv3676.  Studies 
carried out on Rv3676 mutants in M. tuberculosis have demonstrated that Rv3676 is 
required for virulence in a mouse models [108] and the growth of these mutants is 
weakened [108].  Rv3676 mutants are affected in the expression of other genes that could 
be involved in persistence and reactivation of M. tuberculosis, such as “resuscitation 
promoting factor proteins” (Rpfs) [90].  Rpfs can activate the growth of the extended 
stationary phase observed in M. tuberclosis [90].  Little is known about Rv1719.   
It is possible that the Ms/p2196 antisense expressing strain could have affected the 
down-stream signalling pathways involved in multiple mechanisms such as the persistence 
signalling pathways in mycobacteria, or nitrogen-metabolism and glutamine synthesis 
which are important in virulence behaviour of mycobacteria, in this case probably under 
nitrogen starved condition.  
 
 
 
4.4 Future directions 
The starvation growth curves conducted in this study have led to the identification 
of a phenotypic effect of Ms/p2196 antisense in nitrogen-limited media, and proteomic 
analysis has given insight into the functional role of the MSMEG_2196 gene in M. 
smegmatis. Two important experimental approaches need to be conducted before any 
further analyses on MSMEG_2196 are undertaken, first, to find out if MSMEG_2196 
produce c-di-GMP and second, to carry out RT-PCR, or Western blot analysis to test  
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mRNA expression of c-di-GMP in Ms/p2196 antisense.   An experimental approach that 
could be carried out to find if MSMEG_2196 produces cyclic di-GMP is using an 
expression vector where MSMEG_2196 can be expressed then purified.  Nucleotides 
such as GTP could be added to the purified MSMEG_2196 (cyclic di-GMP is synthesised  
from 2 GTP molecules).  Thin layer chromatography (TLC) could be used to confirm the 
conversion of MSMEG_2196 into cyclic di-GMP.   
If MSMEG_2196 produces cyclic di-GMP, is it affecting the expression of 
nitrogen regulatory protein PII (GlnB) and glutamine synthetase type I (GlnA) 
expression?  One experimental approach that could be carried out to answer this question 
is the construction of two promoters whereby one is inserted in front of the glnB gene and 
the other in front of the glnA gene.  Cyclic di-GMP could then be added to the Ms/p2196 
antisense expressing strain grown in nitrogen-limited condition.  2D gel analysis could 
then be carried out to see if nitrogen regulatory protein PII and glutamine synthetase are 
expressed and this could be compared to the culture of Ms/p2196 antisense expressing 
strain grown in nitrogen limited condition in the absence of cyclic di-GMP.   
Since, in other bacteria such as V. cholerae and Psedumonas, cyclic di-GMP is 
found to be involved in virulence [36, 49, 55, and 74] another experimental approach that 
could be carried out is testing the growth of Ms/p2196 antisense expressing strain in 
varying pH values and macrophages. Given that c-di-GMP is involved in the biofilm 
formation and motility of bacteria, Ms/p2196 antisense expressing strain grown in the 
nitrogen-limited condition could be tested for these functions.  The work on constructing 
Mb1389c (in M. bovis), and MSMEG_2196 (in M. smegmatis) mutants should be 
resumed.  To test the role of cyclic di-GMP in virulence in M. bovis, Mb1389c mutants  
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could be tested for pathogenicity of tuberculosis in mice, whereas the cell growth of 
MSMEG_2196 mutants could be tested in nitrogen-limited conditions. 
The Ms/p2196 antisense expressing strain grown in the nitrogen-limited conditions 
had a significant effect (outside of standard errors) on the growth of M. smegmatis.   
Proteomic analysis gave a possible role of MSMEG_2196 in M. smegmatis as a cell 
signalling molecule that could be involved in nitrogen synthesis, of which the latter is 
shown to be of important in physiology and virulence behaviour of M. tuberculosis [57, 
115, 122, and 156] (Reviewed in [114]).  It is possible that MSMEG_2196 is acting as a 
second messenger in mycobacteria, such as in the signalling pathways of nitrogen 
synthesis under nitrogen starvation. This in turn is affecting the down-stream signalling 
pathways of other proteins such as the transcriptional regulator Crp/Fnr proteins and 
glutamate 5-kinase.  Further analysis of cyclic di-GMP as a second messenger in 
mycobacteria needs to be carried out, as there is the possibility of it being used as an anti-
TB drug in tuberculosis.   
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5. Appendices 
 
 5.1  Plasmids  used 
 
 5.1.1 pUHA778 
        
 
 
  110
 5.1.2  pMind 
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 5.2  Hartman-de Bonts (HdeB) minimal media 
 
 
 
100 X metal salts solution 
 
• CaCl2.2H2O  0.10 g 
• CoCl2.2H2O  0.04 g 
• CuSO4.5H2O  0.02 g 
• EDTA   1.00 g 
• FeSO4.7H2O  0.50 g 
• MgCl2.6H2O  10.00 g 
• MnCl2.2H2O  0.10 g 
• NaMoO4.2H2O  0.02 g 
• ZnSO4.7H2O  0.20 g 
Make up to 1 litre and sterilise by autoclaving 
 
 
100 x Nitrogen 
• (NH4)2SO4   200 g 
 
Make up to 1 litre and sterilise by autoclaving 
  
100 x Phosphates 
• K2HPO4   155 g 
• NaH2PO4    85 g 
 
Make up to 1 litre and sterilise by autoclaving 
HdeB base 
• H2O   945 ml 
• 100 x metal salts  10 ml 
• 10% Tween 80   5 ml 
Streilise by autoclaving 
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Carbon starvation (C-) broth 
• HdeB base   960 mL 
• 100 x Nitrogen   10 mL 
• 100 x phosphates  10 mL 
• 10% Glycerol    8 mL 
• Sterile H2O   12 ml 
 
Oxygen starvation (O2-) broth 
• HdeB base   960 mL 
• 100 x Nitrogen   10 mL 
• 100 x Phosphate   10 mL 
• 10% Glycerol    20 mL 
• Sterile H2O     0 mL 
 
Nitrogen starvation (N-) broth 
• HdeB base   960 mL 
• 100 x Nitrogen   0.1 mL 
• 100 x Phosphates   10 mL 
• 10% Glycerol    20 mL 
• Sterile H2O    9.9 mL 
 
Phosphate starvation (P-) broth 
• HdeB base   960 mL 
• 100 x Nitrogen   10 mL 
• 100 x Phosphates    1 mL 
• 10% Glycerol    20 mL 
• 5 M MOPS    10 mL 
• Sterile H2O      0 mL 
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5.3   Preparation and electroporation of Mb1389c-pUHA778 into M. bovis 
WAg203 strain at AgResearch 
  
5.3.1  Preparation of Mb1389c-pUHA778 deletion fragment for electroporation 
 
At AgResearch M. bovis WAg203 strain was used in which the Mb1389c-
pUHA778 fragment was transformed in.   0.3 mL of M. bovis Wag203 were subcultured 
into 1X 100 mL of 7H9 Middlebrook broth containing albumin dextrose catalase (ADC) 
enrichment in a roller bottle and incubated at 37 ºC for up to 1 week.  After which cell 
wall inhibitors (5 mL 30 % glycine, 1 mL M-fluro-DL-phenylanine [MFP], and 1 mL D-
norleucine [DNL]) were added to the cell culture, and incubate at 37 ºC for 2 days.   
Before transformation, the DNA was denatured (to increase transformation 
efficiency), for gene knock-outs, using alkaline denaturation protocol, briefly; 1-2 µg of 
Mb1389-pUHA778 deletion fragment DNA was diluted to 30 µL with sterile distilled 
water, and 3 µL of 2 M NaOH was added and incubated at room temperature for 5 mins.  
To this, 5 µL of 3 M NaOAc, at pH 5, and 120 µL of cold 100 % ethanol was added, 
mixed and incubated at room temperature for 5 mins then centrifuged at 1,4000 rpm for 
another 5 mins.  The supernatants were then removed and 120 µL of 70 % cold ethanol 
added, and centrifuged once again at 1,4000 rpm for 5 mins.  Finally, the supernatants 
were removed and DNA dried, this DNA is ready for use in electro-transformation, 
otherwise it could be stored at 4 ºC overnight.   
 
 
  
5.3.2 Electroporation of Mb1389c-pUHA778 into M. bovis WAg203  
The M. bovis WAg203  culture in 5.3.1 were transferred into 2x 50 mL Falcon 
tubes, 1 mL of this culture was removed to measure OD600 (OD600 of 1.3).  The Falcon 
tubes were centrifuged at 3500 g at room temperature for 10 mins.   The supernatants 
were discarded, and each pair of pellets were resuspended in a small volume (few mL) of 
room temperature heated 10% glycerol, and combined in a total volume of 45 ml 10% 
glycerol.  A second spin was carried out at 3,500 g for another 10 mins, the pellets were 
resuspended into 45 mL of 10 % glycerol as previously and a final spin was performed 
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after which the pellets were resuspended in 600 µL of 10 % glycerol (200 
µL/electroporation).  200 µL of the resuspended M. bovis WAg203 were mixed (by 
pipetting up and down) with precipitated, dried Mb1389c-pUHA778 DNA.  The 
electroporation cuvettes were pre-warmed in 37 °C water bath prior to use.  
Electroporation was carried out at 2.5 kV, 25 uF, 1000 Ω using Bio-Rad Gene Pulser 
electroporator.  For control, blank M. bovis WAg203 was used in a similar manner.  After 
electroporation, the content of each cuvette was transferred to a fresh eppendorf tube and 
incubated at 37 °C over night to recover.  Next day, the electroporated cells were 
resuspended by pipeting up and down, and plated out onto 7H11 Middlebrook (with ADC 
enrichment) Hyg50 plates.  The plates were incubated at 37 °C for about 3 weeks, after 
which colonies were picked and inoculated into 3 mL of 7H9 Middlebrook Hyg50 broth 
(containing ADC enrichment).  The cell cultures were heat killed at AgResearch before 
entering Victoria University PC2 laboratories. 
 
 
 
 5.4  Southern blot  
1. Run a thick gel, 180-200 mL 
• 0.8% - 1.0% agarose gel 
• Run gel at a very slow rate, for example 30 V for 6 hrs, or 60 V for 3 hrs.  
 
2.  Cut 1 piece of Hybond membrane and 3 pieces of Whatman 3 mm filter paper to    exact 
size of gel. 
 
3. Prepare a plastic container as reservoir, a glass plate to sit gel on, 3 pieces of Whatman 
3 mm filter paper as bridge, 2 plastic containers to wash gel, and the following 
solutions: 
 
 
A. Depurination wash 
• 11 mL of conc. HCl 
• Up to 500 mL with dH2O 
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• Or 500 mL of 0.25M HCl acid 
 
B. Denaturation wash 
• 43.83 g of NaCl 
• 10.0 g of NaOH pellets 
• Up to 500 mL with distilled water (make up fresh each time) 
 
C. Neutralization wash 
• 87.66 g of NaCl 
• 60.56 g of Tris 
• 4 mL of 0.5 M EDTA pH 8.0 
• Dissolve in 800 mL dH2O, adjust pH to 7.2 with conc. HCl up to 1 L with dH2O 
 
D. 6X SSC 
• 1 L of 6X SSC from 20X SS 
Method 
Pre-treatment of gel 
• Put gel in first container for washing gel.  Add 500 mL of depurination wash, rock 
for 15 mins at low speed 
 
• Transfer gel into second plastic container, rinse gel with distilled water.  Wash first 
plastic container with distilled water, return gel to first container, and add 500 mL 
denaturation wash.  Rock for 45 min at low speed. 
 
 
• Remove gel from denaturation wash into a rinsed second container, and rinse gel 
with dH2O.  Wash first plastic container with dH2O. 
 
• Transfer gel back to first container and add 500 mL neutralization wash.  Rock for 
15 min at low speed.  Remove gel and repeat neutralization wash with fresh 
solution for 15 min. 
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• Pre-wet the filter paper and nylon membrane in 6X SSC solution, and pour the rest 
of the solution into the reservoir 
 
• Place glass plate on the reservoir container and set up re-wetted bridge.  Make sure 
ends of the bridge are in contact wit the SSC solution in the reservoir. 
 
 
• Carefully slide the gel onto the filter paper bridge, with bottom of gel facing 
upwards. 
 
• With a 10 mL clean disposable pipette, gently roll along surface of gel to remove 
any air bubbles between gel and the filter paper. 
 
• Using forceps lay pre-wetted nylon membrane on top the gel.  Roll gently with 
pipette to remove air bubbles between membrane and gel.  Cut one corner of 
membrane and gel and note orientation. 
 
•  Lay pre-wetted 3 mm filter paper (one by one) on the membrane with forceps, and 
remove bubbles between layers before putting next layer on. 
 
 
• Cover the setup with glad wrap to prevent evaporation of buffer.  Cut and remove 
glad wrap covering gel area. 
 
• Place 1 pack of paper towels on top of filter paper, and put weight (0.5 - 1 kg) on 
paper towels.  Leave overnight for around 18 hrs. 
 
 
• Next morning, dissemble the set up, place the nylon membrane into a folder made 
from blotting or filter paper.  Wrap folder with aluminium foil and bake in 80ºC 
oven for 2 hrs.  Alternatively, wrap the membrane in glad wrap and expose it to UV 
for 1 - 2 mins on each side. 
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Hybridization 
• Prepare 25 mL of hybridization solution (this volume is for small membrane): 
Ingredient  Volume 
20X SSC  7.5 mL 
50X denhardt’s solution  2.5 mL 
10% SDS 1.25 mL 
Salmon sperm DNA (9.1 mg/mL) 0.27 mL 
SDW 13.48 mL 
Total volume 25.00 mL 
 
• Prehybridize membrane in hybridization solution in Hybaid oven set at 60 ºC for 2 
hrs. 
 
• While membrane is prehybridizing, prepare probe. 
 
 
 
Probe preparation 
 
• Dilute template DNA (Mb1389 F4R4 and/or MbF2R4-pGEM-T easy) for probe 
making to 5 ng/µL (I added 10µL of my template), and prepare a mixture of 
dATP/dTTP/dGTP at 5 mM each. 
 
• Mix 10 µL of DNA template with 75 ng of random primers (about 3 µL).   
 
• Boil for 5 mins and put in ice immediately for 5 mins. 
 
• Add 5 µL of 10X NEBuffer 2, 2 µL of 5 mM dATP/dTTP/dGTP mixture, 2 µL of 5 
U/µL Klenow exo- enzymes, and 23 µL of SDW.  In the hot room (radioactive room), 
add 4 µL of ³²P-dCTP to the mixture (the total volume of this mixture is 50 µL). 
 
• Incubate the mixture for 1 hr at 37ºC 
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• Boil probe (95 – 100 ºC) for 5 mins, ice immediately for 5 mins, and add to prehyb.  
Take care not to add probe directly onto membrane. 
 
• Hybridize membranes in Hybaid oven at 60 ºC overnight. 
 
• Next morning, rinse membrane in 2X SSC/0.5% SDS at room temperature for 5 mins, 
followed by 2X SSC/0.1% SDS for 15 mins at room temperature.  Replace the solution 
wit fresh 0.1X SSC/0.5% SDS, and incubate for 30 mins at 65 ºC.  After the incubation, 
rinse membrane briefly with 0.1X SSC. 
 
• Dry membrane briefly (not completely dry) with blotting paper.  Wrap membrane with 
glad wrap. 
 
• Place membranes into cassette and put in a piece of film in the darkroom. 
 
 
 
 
5.5  Gene alignments of Rv1354c against Mb1389c and MSMEG_2196 
 
5.5.1  Rv1354c sequence alignment against Mb1389c 
 
Mtb      601 ATGTGCAACGACACCGCGACGCCGCAGCTTGAGGAGCTCGTCACCACCGTAGCCAACCAG 660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb         1 ATGTGCAACGACACCGCGACGCCGCAGCTTGAGGAGCTCGTCACCACCGTAGCCAACCAG 60 
 
 
Mtb      661 CTCATGACAGTCGACGCTGCCACGTCAGCCGAAGTCAGTCAGCGCGTTTTGGCCTATCTA 720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb        61 CTCATGACAGTCGACGCTGCCACGTCAGCCGAAGTCAGTCAGCGCGTTTTGGCCTATCTA 120 
 
 
Mtb      721 GTGGAACAGCTGGGCGTAGATGTCAGCTTTTTGCGTCATAACGATCGCGACAGGCGCGCG 780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       121 GTGGAACAGCTGGGCGTAGATGTCAGCTTTTTGCGTCATAACGATCGCGACAGGCGCGCG 180 
 
 
Mtb      781 ACGAGGCTGGTGGCCGAATGGCCACCTCGCCTCAACATACCGGACCCCGATCCGCTCAGG 840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       181 ACGAGGCTGGTGGCCGAATGGCCACCTCGCCTCAACATACCGGACCCCGATCCGCTCAGG 240 
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Mtb      841 CTGATCTACTTCGCTGATGCCGACCCGGTGTTTGCGCTATGCGAACACGCCAAAGAGCCT 900 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       241 CTGATCTACTTCGCTGATGCCGACCCGGTGTTTGCGCTATGCGAACACGCCAAAGAGCCT 300 
 
 
Mtb      901 CTCGTGTTCCGGCCCGAGCCGGCCACCGAGGACTATCAACGCCTCATCGAAGAAGCCCGC 960 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       301 CTCGTGTTCCGGCCCGAGCCGGCCACCGAGGACTATCAACGCCTCATCGAAGAAGCCCGC 360 
 
 
Mtb      961 GGGGTTCCGGTAACGTCGGCTGCCGCCGTGCCGCTGGTATCTGGCGAGATCACCACTGGA 1020 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       361 GGGGTTCCGGTAACGTCGGCTGCCGCCGTGCCGCTGGTATCTGGCGAGATCACCACTGGA 420 
 
 
 
Mtb     1021 CTGCTGGGGTTCATCAAGTTCGGTGATCGGAAATGGCACGAGGCCGAGCTTAACGCCCTC 1080 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       421 CTGCTGGGGTTCATCAAGTTCGGTGATCGGAAATGGCACGAGGCCGAGCTTAACGCCCTC 480 
 
 
Mtb     1081 ATGACCATCGCTACACTCTTCGCCCAGGTGCAGGCTCGCGTCGCCGCCGAGGCGCGGCTT 1140 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       481 ATGACCATCGCTACACTCTTCGCCCAGGTGCAGGCTCGCGTCGCCGCCGAGGCGCGGCTT 540 
 
 
Mtb     1141 CGCTATCTGGCCGACCATGACGATCTGACCGGACTGCATAACCGTCGCGCGTTGCTGCAG 1200 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       541 CGCTATCTGGCCGACCATGACGATCTGACCGGACTGCATAACCGTCGCGCGTTGCTGCAG 600 
 
 
Mtb     1201 CACCTGGACCAAAGACTGGCCCCCGGACAACCTGGCCCGGTCGCGGCGCTATTTCTCGAC 1260 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       601 CACCTGGACCAAAGACTGGCCCCCGGACAACCTGGCCCGGTCGCGGCGCTATTTCTCGAC 660 
 
 
Mtb     1261 TTGGACCGCCTCAAGGCCATCAACGACTACCTGGGCCACGCCGCCGGTGACCAGTTCATC 1320 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       661 TTGGACCGCCTCAAGGCCATCAACGACTACCTGGGCCACGCCGCCGGTGACCAGTTCATC 720 
 
 
Mtb     1321 CATGTGTTCGCCCAACGGATCGGTGACGCACTCGTTGGCGAGAGCCTGATCGCCCGACTC 1380 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       721 CATGTGTTCGCCCAACGGATCGGTGACGCACTCGTTGGCGAGAGCCTGATCGCCCGACTC 780 
 
 
Mtb     1381 GGCGGCGACGAATTCGTCCTCATACCCGCATCTCCAATGAGTGCCGATGCCGCTCAACCG 1440 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       781 GGCGGCGACGAATTCGTCCTCATACCCGCATCTCCAATGAGTGCCGATGCCGCTCAACCG 840 
 
 
Mtb      1441 CTCGCCGAACGTCTTCGCGACCAGCTCAAGGACCACGTCGCTATCGGCGGTGAGGTGCTC 1500 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb        841 CTCGCCGAACGTCTTCGCGACCAGCTCAAGGACCACGTCGCTATCGGCGGTGAGGTGCTC 900 
 
 
Mtb      1501 ACCCGCACCGTCAGTATCGGTGTCGCCTCAGGGACTCCCGGACAGCACACACCGTCGGAC 1560 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb        901 ACCCGCACCGTCAGTATCGGTGTCGCCTCAGGGACTCCCGGACAGCACACACCGTCGGAC 960 
 
 
Mtb      1561 CTCCTGCGCCGAGCCGACCAAGCCGCTCTGGCAGCCAAACACGCCGGCGGAGATAGCGTC 1620 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb        961 CTCCTGCGCCGAGCCGACCAAGCCGCTCTGGCAGCCAAACACGCCGGCGGAGATAGCGTC 1020 
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Mtb      1621 GCGATTTTCACCGCGGACATGTCGGTCAGCGGCGAACTGCGCAACGATATTGAACTACAC 1680 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1021 GCGATTTTCACCGCGGACATGTCGGTCAGCGGCGAACTGCGCAACGATATTGAACTACAC 1080 
 
 
Mtb      1681 CTTCGACGTGGTATCGAATCCGACGCCCTTCGCCTGGTCTACCTACCCGAGGTCGACCTA 1740 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1081 CTTCGACGTGGTATCGAATCCGACGCCCTTCGCCTGGTCTACCTACCCGAGGTCGACCTA 1140 
 
 
Mtb      1741 CGGACCGGCGACATTGTCGGGACCGAGGCATTGGTCCGGTGGCAGCACCCCACCCGTGGG 1800 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1141 CGGACCGGCGACATTGTCGGGACCGAGGCATTGGTCCGGTGGCAGCACCCCACCCGTGGG 1200 
 
 
Mtb      1801 CTGCTGGCACCGGGCTGCTTCATCCCTGTGGCCGAATCCATCAACCTTGCAGGCGAATTG 1860 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1201 CTGCTGGCACCGGGCTGCTTCATCCCTGTGGCCGAATCCATCAACCTTGCAGGCGAATTG 1260 
 
 
Mtb      1861 GATAGATGGGTGCTGCGGAGGGCCTGCAATGAATTCTCCGAGTGGCAGTCAGCCGGTTTG 1920 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1261 GATAGATGGGTGCTGCGGAGGGCCTGCAATGAATTCTCCGAGTGGCAGTCAGCCGGTTTG 1320 
 
 
Mtb      1921 GGCCACGACGCGCTGCTGCGTATCAACGTCTCAGCTGGACAGCTGGTGACGGGCGGGTTT 1980 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1321 GGCCACGACGCGCTGCTGCGTATCAACGTCTCAGCTGGACAGCTGGTGACGGGCGGGTTT 1380 
 
 
Mtb      1981 GTTGACTTCGTCGCAGACACGATCGGCCAGCACGGTCTGGACGCCTCGTCCGTGTGTTTG 2040 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1381 GTTGACTTCGTCGCAGACACGATCGGCCAGCACGGTCTGGACGCCTCGTCCGTGTGTTTG 1440 
 
 
Mtb      2041 GAAATCACCGAAAACGTTGTGGTGCAAGACCTACATACCGCCAGAGCCACCCTGGCTCGA 2100 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1441 GAAATCACCGAAAACGTTGTGGTGCAAGACCTACATACCGCCAGAGCCACCCTGGCTCGA 1500 
 
 
Mtb      2101 CTCAAAGAAGTCGGCGTTCACATCGCTATCGACGATTTCGGCACCGGCTATAGCGCCATA 2160 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1501 CTCAAAGAAGTCGGCGTTCACATCGCTATCGACGATTTCGGCACCGGCTATAGCGCCATA 1560 
 
 
Mtb      2161 TCACTGTTGCAGACGCTACCGATCGACACGCTCAAGATCGACAAAACATTCGTGCGGCAA 2220 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1561 TCACTGTTGCAGACGCTACCGATCGACACGCTCAAGATCGACAAAACATTCGTGCGGCAA 1620 
 
 
Mtb       222 CTCGGAACCAACACTAGCGATCTGGTCATTGTGCGCGGCATCATGACACTCGCCGAAGGC 2280 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1621 CTCGGAACCAACACTAGCGATCTGGTCATTGTGCGCGGCATCATGACACTCGCCGAAGGC 1680 
 
 
Mtb      2281 TTCCAACTCGATGTAGTAGCCGAAGGCGTCGAGACCGAGGCTGCCGCCAGAATTCTATTG 2340 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1681 TTCCAACTCGATGTAGTAGCCGAAGGCGTCGAGACCGAGGCTGCCGCCAGAATTCTATTG 1740 
 
 
Mtb      2341 GATCAGCGCTGTTACCGTGCGCAAGGCTTCTTGTTCTCCCGGCCTGTCCCCGGGGAGGCC 2400 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1741 GATCAGCGCTGTTACCGTGCGCAAGGCTTCTTGTTCTCCCGGCCTGTCCCCGGGGAGGCC 1800 
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Mtb      2401 ATGCGGCACATGTTGTCCGCACGACGACTACCGCCGACCTGCATACCTGCAACTGACCCG 2460 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Mb       1801 ATGCGGCACATGTTGTCCGCACGACGACTACCGCCGACCTGCATACCTGCAACTGACCCG 1860 
 
Mtb      2461 GCGTTATCTTGA 2472 
              |||||||||||| 
Mb       1861 GCGTTATCTTGA 1872 
 
 
 
 
 
5.5.2  Rv1354c sequence alignment against MSMEG_2196 
 
Mtb        622 CCGC-AGCTTG-AGGAGCTCGTCACCACCGTAGCCAACCAGCTCATGACAGTCGACGCTG 679 
               |||  ||| || | | ||| |||||  |||| ||||  ||||||||| ||||||| || | 
M.smeg       5 CCGAGAGCCTGGACGTGCTGGTCACGTCCGTCGCCACTCAGCTCATGGCAGTCGAGGCGG 64 
 
 
Mtb        680 CCACGTCAGCCGAAGTCAGTCAGCGCGTTTTGGCCTATCTAGTGGAACAGCTGGGCGTAG 739 
               |||| || |     ||||| ||||  ||  | ||| | || |||       | |  || | 
M.smeg      65 CCACCTCGGTGTCGGTCAGCCAGCAGGTGCTCGCCGAACTGGTGTCGTTCTTCGATGTCG 124 
 
 
Mtb        740 ATGTCAGCTTTTTGCGTCATAACGATCGCGACAGGCGCGCGACGAGGCTGGTGGCCGAAT 799 
               |||| |||||  |||| || ||||| | |  |   | ||| |||||||| || ||||| | 
M.smeg     125 ATGTGAGCTTCCTGCGCCACAACGACCACCGCGCCCACGCCACGAGGCTCGTCGCCGAGT 184 
 
 
Mtb        800 GGCCACCTCGCCTCAACATAC-CGGACCCCGATCCGCTCAGGC-TGATCTACTTCGCTGA 857 
               |||| || || |    |  || | | | |||| ||| || | | |  || ||||||| || 
M.smeg     185 GGCCGCCGCGTCCGGTCG-ACGCCGCCACCGACCCGATC-GCCGTCGTCCACTTCGCCGA 242 
 
 
Mtb        858 TGCCGACCCGGTGTTTGCGCTATGCGAACACGCCAAAGAGCCTCTCG-TGTTCCGGCCCG 916 
               ||||||||||||||| ||  |   |||||||  ||| || || | || |||||||||||| 
M.smeg     243 TGCCGACCCGGTGTTCGCCATGGCCGAACACCTCAAGGAACC-CGCGGTGTTCCGGCCCG 301 
 
 
Mtb        917 AGCCGGCCACCGAGGACTATCAACGCCTCATCGAAGAAGCCCGCGGGGTTCCGGTAACGT 976 
               | |||  |  ||| |||||||| |||  |||||| | || |||     | || |  |||| 
M.smeg     302 AACCGCTCTACGACGACTATCAGCGCACCATCGAGGCAGGCCGGCACATCCCCGCCACGT 361 
 
 
Mtb       977 CGGCTGCCGC-CGTGCCGCTGGT-ATCTGGCGAGATCACCACTGGACTGCTGGGGTTCAT 1034 
               ||  || ||  ||| |||||| | | | |||||  |||| || ||  ||||||| ||| | 
M.smeg    362 CGA-TGGCGTGCGTCCCGCTGCTCAGC-GGCGACGTCACGACCGGTGTGCTGGGCTTCGT 419 
 
 
Mtb       1035 CAAGTTCGGTGATCGGAAATGGCACGAGGCCGAGCTTAACGCCCTCATGACCATCGCTAC 1094 
               ||||||||| || ||  | ||||     || || || ||||| |||| | | |||||  | 
M.smeg     420 CAAGTTCGGCGACCGCGAGTGGCTGCCCGCAGAACTCAACGCGCTCAAGGCGATCGCGTC 479 
 
 
Mtb      1095 ACTCTTCGCCCAGGTGCAGGCTCGCGTCGCCGCCGAGGCGCGGCTTCGCTATCTGGCCGA 1154 
                | ||||| ||||||||||| ||  |||  |||||||  || || || || |||||||| 
M.smeg    480 GTTGTTCGCGCAGGTGCAGGCCCGGATCGAGGCCGAGGAACGCCTGCGTTACCTGGCCGA 539 
 
 
Mtb      1155 CCATGACGATCTGACCGGACTGCATAACCGTCGCGCGTTGCTGCAGCACCTGGACCAAAG 1214 
              ||| ||  | |||||||| ||| | |||||||||||  || ||  |||||||||    || 
M.smeg    540 CCACGATCACCTGACCGGCCTGTACAACCGTCGCGCCCTGATGGCGCACCTGGAAGCGAG 599 
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Mtb      1215 ACTGGCCCCCGGACAACCTGGCCCGGTCGCGGCGCTATTTCTCGACTTGGACCGCCTCAA 1274 
              ||| || || |||||||| || |||||||||| | | ||  ||||| ||||||| || || 
M.smeg    600 ACTCGCTCCGGGACAACCCGGTCCGGTCGCGGTGATGTTCTTCGACCTGGACCGGCTGAA 659 
 
 
Mtb      1275 GGCCATCAACGACTACCTGGGCCACGCCGCCGGTGACCAGTTCATCCATGTGTTCGCCCA 1334 
              ||| ||||||||||||||||| ||| |||| ||||||  |||||||    |  |||| || 
M.smeg    660 GGCGATCAACGACTACCTGGGTCACACCGCGGGTGACGCGTTCATCAGCATCCTCGCGCA 719 
 
 
Mtb      1335 ACGGATCGGTGACGCACT--CGTTGGCGAGAGCCTGATCGCCCGACTCGGCGGCGACGAA 1392 
               || | | |  ||||  |  ||  |    ||  ||||| || || ||||||||||||||  
M.smeg    720 GCG-A-CTGCAACGCGGTGACGACGCTCCGAAGCTGATAGCGCGCCTCGGCGGCGACGAG 777 
Mtb      1393 TTCGTCCTCATACCCGCATCTCCAATGAGTGCCG-ATGCCGCTCAAC-CGCTCGCCGAAC 1450 
              |||||| || | ||||    ||| |||   || | |||  || || | |||| ||| | | 
M.smeg    778 TTCGTCGTCGTCCCCGACGATCCCATGTC-GCTGGATGAGGC-CACCGCGCTGGCCTACC 835 
 
 
Mtb      1451 GTCTTCGCGACCA-GCTCAAGGACCACGTCGCTATCGGCGGTGAGGTGCTCACCCGCACC 1509 
              | || |  | |   |||    || | |||| |  ||| ||||||| ||||||| || ||| 
M.smeg    836 GGCTGCA-GTCGGTGCTGCGCGAACGCGTCACCGTCGACGGTGAGATGCTCACTCGAACC 894 
 
 
Mtb      1510 GTCAGTATCGGTGTCGCCTCAGGGACTCCCGGACAGCACACACCGTCGGACCTCCTGCGC 1569 
              || || |||||| ||||   ||| | ||| ||  || |  || |||| ||| | ||   | 
M.smeg    895 GTGAGCATCGGTATCGCACAAGGCATTCCGGGTAAGGATTCAACGTCCGACGTGCTCAAC 954 
 
 
Mtb      1570 CGAGCCGACCAAGCCGCTCTGGCAGCCAAACACGCCGGCGGAGATAGCGTCGCGATTTTC 1629 
              || |||||||| || |   || | |||||     |||||||  |  |||||||| | ||| 
M.smeg    955 CGGGCCGACCACGCGGTATTGACGGCCAAGGGTTCCGGCGGCAACCGCGTCGCGGTCTTC 1014 
 
 
Mtb      1630 ACCGCGGACATGTCGGTCAGCGG-CGAACTGCGCAACGATATTGAACTACACCTTC-GA- 1686 
               |||  |  ||| |  |  | |  |||  | |||||||| || ||||| ||||| | ||  
M.smeg   1015 TCCGACGCGATGGCCATG-GAGATCGACTTCCGCAACGACATCGAACTGCACCTGCAGAG 1073 
 
 
Mtb      1687 CGTGGTATCGAATCCGACGCCCTTCGCCTGGTCTACCTACCCGAGGTCGACCTACGGACC 1746 
              ||||  ||||||  || ||| ||    |||  |||||| || ||  ||||| | || ||| 
M.smeg   1074 CGTG--ATCGAAGGCGGCGCACTGGTGCTGCACTACCTGCCGGAAATCGACATGCGCACC 1131 
 
 
Mtb      1747 GGCGACATTGTCGGGACCGAGGCATTGGTCCGGTGGCAGCACCCCACCCGTGGGCTGCTG 1806 
              || ||  |  | | | | || ||  ||||||| ||| |||| |||||||| || |||||| 
M.smeg   1132 GGTGAGGTGCTGGCGGCAGAAGCGCTGGTCCGCTGGGAGCATCCCACCCGCGGCCTGCTG 1191 
 
 
Mtb      1807 GCACCGGGCTGCTTCATCCCTGTGGCCGAATCCATCAACCTTGCAGGCGAATTGGATAGA 1866 
               | || | ||  ||||||   ||||||||||| |||||||| ||||| ||| |||   |  
M.smeg   1192 TCGCCCGACTCGTTCATCGGCGTGGCCGAATCGATCAACCTCGCAGGGGAACTGGGCCGG 1251 
 
 
Mtb      1867 TGGGTGCTGCGGAGGGCCTGCAATGAATTCTCCGAGTGGCAGTCAGCCGGTTTGGGCCAC 1926 
              ||||||||||| | ||| |||   || ||||||  ||||| | |   |||  |||||| | 
M.smeg   1252 TGGGTGCTGCGCACGGCATGCGCCGAGTTCTCCCGGTGGCGGGCCAACGGCGTGGGCCGC 1311 
 
 
Mtb      1927 GACG-CGCTGCTGCGTATCAACGTCTCAGCTGGACAGCTGGTGACGGGCGGGTTTGTTGA 1985 
               ||  || |  |||| |||||||||||| | |  ||||| ||||| | ||| || || || 
M.smeg   1312 AACATCG-TCTTGCGGATCAACGTCTCACCGGTCCAGCTCGTGACCGACGGATTCGTCGA 1370 
 
 
Mtb      1986 CTTCGTCGCAGACACGATCGGCCAGCACGGTCTGGACGC-CTCGTCCGTGTGTTTGGAAA 2044 
               |  || || | ||  ||     ||  |||||||  ||| |  ||| |||||| |||| | 
M.smeg   1371 GTCGGTGGCGGGCATCATGAAAGAGTTCGGTCTGC-CGCGCGGGTCGGTGTGTCTGGAGA 1429 
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Mtb      2045 TCACCGAAAACGTTGTGGTGCAAGACCTACATACCGCCAGAGCCACCCTGGCTCGACT-C 2103 
              ||||||||| |||||||||||| ||| |  | ||| || |  |||| ||| |  | || | 
M.smeg   1430 TCACCGAAAGCGTTGTGGTGCAGGACATCGAGACCACCCGCACCACGCTGACGGGTCTGC 1489 
 
 
Mtb      2104 AAAGAAGTCGGCGTTCACATCGCTATCGACGATTTCGGCACCGGCTATAGCGCCATATCA 2163 
              | | | |||||||| ||  | || |||||||||||||||||||| || ||||   | ||  
M.smeg   1490 ACA-ACGTCGGCGTCCAGGTGGCCATCGACGATTTCGGCACCGGTTACAGCGTGTTGTCG 1548 
 
 
Mtb      2164 CTGTTGCAGACGCTACCGATCGACACGCTCAAGATCGACAAAACATTCGTGCGGC-AACT 2222 
              ||| || |  | || ||| | |||||||| |||||||||   |  |||||| | | |||| 
M.smeg   1549 CTGCTGAAATCACTGCCGGTGGACACGCTGAAGATCGACCGCAGCTTCGTG-GCCGAACT 1607 
 
 
Mtb      2223 CGGAACCAACACTAGCGATCTGGTCATTGTGCGCGGCATCATGACACTCGCCGAAGGCTT 2282 
               ||  ||||| |  |||| ||    || ||||| | | | ||  | || || |  | ||| 
M.smeg   1608 GGGCTCCAACCCGGGCGACCTTCCGATCGTGCGGGCCGTGATCGCGCTGGCGGGGGCCTT 1667 
 
 
Mtb      2283 CCAACTCGATGTAGTAGCCGAAGGCGTCGAGACCGAG-GCTGCCGCCAGAATTCTATTGG 2341 
              |  |||  |  | || ||||| ||||| ||||||||| || |||||    |  ||  ||  
M.smeg   1668 CGGACTACAACTGGTGGCCGAGGGCGTGGAGACCGAGCGC-GCCGCGCTCACCCTGCTGC 1726 
 
 
Mtb      2342 ATCAGCGCTGTTACCGTGCGCAAGGCTTCTTGTTCTCCCGGCCTGTCCCCGGGGAG-GCC 2400 
                ||  | |||||||| ||||| || ||| || | |||   ||  |||  ||| || |   
M.smeg   1727 GCCACGGGTGTTACCGCGCGCAGGGGTTCCTGCTGTCCAAACCCATCCT-GGGCAGTGAG 1785 
 
 
Mtb      2401 ATGCGG-CACATGTTGTCCGCACGACGACTACCGCCGACCTGCATACCTGCAACT 2454 
              |||| | | | | ||| ||  | | ||  | |||  |  || |  | ||||  || 
M.smeg   1786 ATGCAGACCCTTCTTG-CCAAAGGCCGTGTGCCGGTGCACTTCTCAGCTGCGCCT 1839 
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5.6   Mb1389c and MSMEG_2196 gene and protein sequences 
 
 
 
5.6.1  Mb1389c gene sequence 
 
ATGTGCAACGACACCGCGACGCCGCAGCTTGAGGAGCTCGTCACCACCGTAGCCAACCAG 
CTCATGACAGTCGACGCTGCCACGTCAGCCGAAGTCAGTCAGCGCGTTTTGGCCTATCTA 
GTGGAACAGCTGGGCGTAGATGTCAGCTTTTTGCGTCATAACGATCGCGACAGGCGCGCG 
ACGAGGCTGGTGGCCGAATGGCCACCTCGCCTCAACATACCGGACCCCGATCCGCTCAGG 
CTGATCTACTTCGCTGATGCCGACCCGGTGTTTGCGCTATGCGAACACGCCAAAGAGCCT 
CTCGTGTTCCGGCCCGAGCCGGCCACCGAGGACTATCAACGCCTCATCGAAGAAGCCCGC 
GGGGTTCCGGTAACGTCGGCTGCCGCCGTGCCGCTGGTATCTGGCGAGATCACCACTGGA 
CTGCTGGGGTTCATCAAGTTCGGTGATCGGAAATGGCACGAGGCCGAGCTTAACGCCCTC 
ATGACCATCGCTACACTCTTCGCCCAGGTGCAGGCTCGCGTCGCCGCCGAGGCGCGGCTT 
CGCTATCTGGCCGACCATGACGATCTGACCGGACTGCATAACCGTCGCGCGTTGCTGCAG 
CACCTGGACCAAAGACTGGCCCCCGGACAACCTGGCCCGGTCGCGGCGCTATTTCTCGAC 
TTGGACCGCCTCAAGGCCATCAACGACTACCTGGGCCACGCCGCCGGTGACCAGTTCATC 
CATGTGTTCGCCCAACGGATCGGTGACGCACTCGTTGGCGAGAGCCTGATCGCCCGACTC 
GGCGGCGACGAATTCGTCCTCATACCCGCATCTCCAATGAGTGCCGATGCCGCTCAACCG 
CTCGCCGAACGTCTTCGCGACCAGCTCAAGGACCACGTCGCTATCGGCGGTGAGGTGCTC 
ACCCGCACCGTCAGTATCGGTGTCGCCTCAGGGACTCCCGGACAGCACACACCGTCGGAC 
CTCCTGCGCCGAGCCGACCAAGCCGCTCTGGCAGCCAAACACGCCGGCGGAGATAGCGTC 
GCGATTTTCACCGCGGACATGTCGGTCAGCGGCGAACTGCGCAACGATATTGAACTACAC 
CTTCGACGTGGTATCGAATCCGACGCCCTTCGCCTGGTCTACCTACCCGAGGTCGACCTA 
CGGACCGGCGACATTGTCGGGACCGAGGCATTGGTCCGGTGGCAGCACCCCACCCGTGGG 
CTGCTGGCACCGGGCTGCTTCATCCCTGTGGCCGAATCCATCAACCTTGCAGGCGAATTG 
GATAGATGGGTGCTGCGGAGGGCCTGCAATGAATTCTCCGAGTGGCAGTCAGCCGGTTTG 
GGCCACGACGCGCTGCTGCGTATCAACGTCTCAGCTGGACAGCTGGTGACGGGCGGGTTT 
GTTGACTTCGTCGCAGACACGATCGGCCAGCACGGTCTGGACGCCTCGTCCGTGTGTTTG 
GAAATCACCGAAAACGTTGTGGTGCAAGACCTACATACCGCCAGAGCCACCCTGGCTCGA 
CTCAAAGAAGTCGGCGTTCACATCGCTATCGACGATTTCGGCACCGGCTATAGCGCCATA 
TCACTGTTGCAGACGCTACCGATCGACACGCTCAAGATCGACAAAACATTCGTGCGGCAA 
CTCGGAACCAACACTAGCGATCTGGTCATTGTGCGCGGCATCATGACACTCGCCGAAGGC 
TTCCAACTCGATGTAGTAGCCGAAGGCGTCGAGACCGAGGCTGCCGCCAGAATTCTATTG 
GATCAGCGCTGTTACCGTGCGCAAGGCTTCTTGTTCTCCCGGCCTGTCCCCGGGGAGGCC 
ATGCGGCACATGTTGTCCGCACGACGACTACCGCCGACCTGCATACCTGCAACTGACCCG 
GCGTTATCTTG. 
 
 
 
 
5.6.2  Mb1389c protein sequence 
 
MCNDTATPQLEELVTTVANQLMTVDAATSAEVSQRVLAYLVEQLGVDVSFLRHNDRDRRA 
TRLVAEWPPRLNIPDPDPLRLIYFADADPVFALCEHAKEPLVFRPEPATEDYQRLIEEAR 
GVPVTSAAAVPLVSGEITTGLLGFIKFGDRKWHEAELNALMTIATLFAQVQARVAAEARL 
RYLADHDDLTGLHNRRALLQHLDQRLAPGQPGPVAALFLDLDRLKAINDYLGHAAGDQFI 
HVFAQRIGDALVGESLIARLGGDEFVLIPASPMSADAAQPLAERLRDQLKDHVAIGGEVL 
TRTVSIGVASGTPGQHTPSDLLRRADQAALAAKHAGGDSVAIFTADMSVSGELRNDIELH 
LRRGIESDALRLVYLPEVDLRTGDIVGTEALVRWQHPTRGLLAPGCFIPVAESINLAGEL 
DRWVLRRACNEFSEWQSAGLGHDALLRINVSAGQLVTGGFVDFVADTIGQHGLDASSVCL 
EITENVVVQDLHTARATLARLKEVGVHIAIDDFGTGYSAISLLQTLPIDTLKIDKTFVRQ 
LGTNTSDLVIVRGIMTLAEGFQLDVVAEGVETEAAARILLDQRCYRAQGFLFSRPVPGEA 
MRHMLSARRLPPTCIPATDPALS. 
 
  125
5.6.3  MSMEG_2196 gene sequence 
 
GTGTCCGAGAGCCTGGACGTGCTGGTCACGTCCGTCGCCACTCAGCTCATGGCAGTCGAG 
GCGGCCACCTCGGTGTCGGTCAGCCAGCAGGTGCTCGCCGAACTGGTGTCGTTCTTCGAT 
GTCGATGTGAGCTTCCTGCGCCACAACGACCACCGCGCCCACGCCACGAGGCTCGTCGCC 
GAGTGGCCGCCGCGTCCGGTCGACGCCGCCACCGACCCGATCGCCGTCGTCCACTTCGCC 
GATGCCGACCCGGTGTTCGCCATGGCCGAACACCTCAAGGAACCCGCGGTGTTCCGGCCC 
GAACCGCTCTACGACGACTATCAGCGCACCATCGAGGCAGGCCGGCACATCCCCGCCACG 
TCGATGGCGTGCGTCCCGCTGCTCAGCGGCGACGTCACGACCGGTGTGCTGGGCTTCGTC 
AAGTTCGGCGACCGCGAGTGGCTGCCCGCAGAACTCAACGCGCTCAAGGCGATCGCGTCG 
TTGTTCGCGCAGGTGCAGGCCCGGATCGAGGCCGAGGAACGCCTGCGTTACCTGGCCGAC 
CACGATCACCTGACCGGCCTGTACAACCGTCGCGCCCTGATGGCGCACCTGGAAGCGAGA 
CTCGCTCCGGGACAACCCGGTCCGGTCGCGGTGATGTTCTTCGACCTGGACCGGCTGAAG 
GCGATCAACGACTACCTGGGTCACACCGCGGGTGACGCGTTCATCAGCATCCTCGCGCAG 
CGACTGCAACGCGGTGACGACGCTCCGAAGCTGATAGCGCGCCTCGGCGGCGACGAGTTC 
GTCGTCGTCCCCGACGATCCCATGTCGCTGGATGAGGCCACCGCGCTGGCCTACCGGCTG 
CAGTCGGTGCTGCGCGAACGCGTCACCGTCGACGGTGAGATGCTCACTCGAACCGTGAGC 
ATCGGTATCGCACAAGGCATTCCGGGTAAGGATTCAACGTCCGACGTGCTCAACCGGGCC 
GACCACGCGGTATTGACGGCCAAGGGTTCCGGCGGCAACCGCGTCGCGGTCTTCTCCGAC 
GCGATGGCCATGGAGATCGACTTCCGCAACGACATCGAACTGCACCTGCAGAGCGTGATC 
GAAGGCGGCGCACTGGTGCTGCACTACCTGCCGGAAATCGACATGCGCACCGGTGAGGTG 
CTGGCGGCAGAAGCGCTGGTCCGCTGGGAGCATCCCACCCGCGGCCTGCTGTCGCCCGAC 
TCGTTCATCGGCGTGGCCGAATCGATCAACCTCGCAGGGGAACTGGGCCGGTGGGTGCTG 
CGCACGGCATGCGCCGAGTTCTCCCGGTGGCGGGCCAACGGCGTGGGCCGCAACATCGTC 
TTGCGGATCAACGTCTCACCGGTCCAGCTCGTGACCGACGGATTCGTCGAGTCGGTGGCG 
GGCATCATGAAAGAGTTCGGTCTGCCGCGCGGGTCGGTGTGTCTGGAGATCACCGAAAGC 
GTTGTGGTGCAGGACATCGAGACCACCCGCACCACGCTGACGGGTCTGCACAACGTCGGC 
GTCCAGGTGGCCATCGACGATTTCGGCACCGGTTACAGCGTGTTGTCGCTGCTGAAATCA 
CTGCCGGTGGACACGCTGAAGATCGACCGCAGCTTCGTGGCCGAACTGGGCTCCAACCCG 
GGCGACCTTCCGATCGTGCGGGCCGTGATCGCGCTGGCGGGGGCCTTCGGACTACAACTG 
GTGGCCGAGGGCGTGGAGACCGAGCGCGCCGCGCTCACCCTGCTGCGCCACGGGTGTTAC 
CGCGCGCAGGGGTTCCTGCTGTCCAAACCCATCCTGGGCAGTGAGATGCAGACCCTTCTT 
GCCAAAGGCCGTGTGCCGGTGCACTTCTCAGCTGCGCCTCGCATGTGA. 
 
 
 
 
 
 
5.6.4 MSMEG_2196 protein sequence 
 
MSESLDVLVTSVATQLMAVEAATSVSVSQQVLAELVSFFDVDVSFLRHNDHRAHATRLVA 
EWPPRPVDAATDPIAVVHFADADPVFAMAEHLKEPAVFRPEPLYDDYQRTIEAGRHIPAT 
SMACVPLLSGDVTTGVLGFVKFGDREWLPAELNALKAIASLFAQVQARIEAEERLRYLAD 
HDHLTGLYNRRALMAHLEARLAPGQPGPVAVMFFDLDRLKAINDYLGHTAGDAFISILAQ 
RLQRGDDAPKLIARLGGDEFVVVPDDPMSLDEATALAYRLQSVLRERVTVDGEMLTRTVS 
IGIAQGIPGKDSTSDVLNRADHAVLTAKGSGGNRVAVFSDAMAMEIDFRNDIELHLQSVI 
EGGALVLHYLPEIDMRTGEVLAAEALVRWEHPTRGLLSPDSFIGVAESINLAGELGRWVL 
RTACAEFSRWRANGVGRNIVLRINVSPVQLVTDGFVESVAGIMKEFGLPRGSVCLEITES 
VVVQDIETTRTTLTGLHNVGVQVAIDDFGTGYSVLSLLKSLPVDTLKIDRSFVAELGSNP 
GDLPIVRAVIALAGAFGLQLVAEGVETERAALTLLRHGCYRAQGFLLSKPILGSEMQTLL 
AKGRVPVHFSAAPRM. 
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